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Abstract and Keywords
A threat appraisal model grounded in Protection Motivation Theory (PMT) determined
whether providing health information regarding perceived severity (PS) and perceived
vulnerability (PS) of vaping health complications, corroborates with reduced vaping-related
intention and habitual behaviour. Seventy-seven regular vapers (22.21 ± 3.47 years) registered
within a Canadian university were randomized into one of two groups, wherein the
aforementioned threat appraisal information was present. Participants in the experimental group
(n = 41) watched an 8-minute information video a week after baseline, following the threat
appraisal components of PMT. Those in the attention control group (n = 36) watched an
information video on nutrition and healthy lifestyle. Data were collected for PV, PS, vaping
intentions, and vaping behaviour at baseline and the following 3 time points after the
intervention: Day-7, Day-30, and Day-45. A complete (n = 77) and imputed (n = 416) analysis
for missing data revealed a significant treatment group by time interaction effect for PV and PS.
Specifically, those in the experimental group reported higher PV and PS scores, compared to
their attention control counterparts. For vaping intention, the treatment group by time interaction
effect was significant for imputed but not complete data. In both analyses, intentions to vape less,
particularly immediately after the intervention was evident in the experimental group but not in
the attention control group. For vaping behavior, the treatment group by time interact effect was
significant for imputed but not complete data. In both analyses, vaping use after the intervention
dropped for both groups, however the drop for those in the experimental group was more
pronounced than the drop for those in the attention control group. Both PS and PV were
correlated with vaping intention at all assessment time points. Specifically, higher PS and PV
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scores were associated with intentions to vape less. Weak and inconsistent evidence was
provided that intentions to vape less is correlated with actually vaping less. It is suggested
through this study that the threat appraisal components of PMT (i.e., PS and PV) can be
successfully manipulated among University vapers, which in turn can reduce their intentions to
vape and to a lesser extent reduce their actual vaping use. Implications for future vaping
intervention research within a public health education framework, are discussed.
Keywords: vaping, protection motivation theory, threat appraisal, intention, behaviour
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Lay Summary
As a relatively new device in North America, the Lung Association of Canada has been
unsuccessful in gaining stricter regulation of vaping products across the country. Since the spike
in vaping-related illnesses in 2019, statistics Canada states that young adults were the main users
of vaping products, attributed to the mislead understanding that vaping is not harmful to their
health. The purpose of this study is to investigate if the use of an 8-minute informational video,
following the threat principles of the Protection Motivation Theory (PMT), lowers vaping
intention and behaviour in Canadian university students over a 6-week study period. Another
goal was to see if the two factors of threat (perceived severity and perceived vulnerability) are
individually linked with changes in intention and if that intention can cause actual reductions in
vaping use. In this study there were two groups of participants, those who received specific
information about the risks of vaping and those who received general facts about nutrition and
health. Both groups were asked to complete self-report questionnaires at four separate timepoints
within a 6-week study period. From this design, it was revealed that PMT health risk information
does cause vaping intentions to change and both factors of threat (PS and PV) have a strong
effect on intention. However, those intentions do not translate to lowered vaping use. As a result,
although using health risk information can cause regular vapers in university to have intentions
to vape less, there needs to be more research done on how to convert those intentions into actual
behaviour change for vaping.
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Chapter 1
1

Introduction
According to Statistics Canada, more than one-third of Canadian students have tried

vaping products at some point in their lives with the highest rates of trying vaping being among
young adults (18-24 years). These data points reinforce the trend that vaping is becoming
increasingly popular among Canadians, specifically among Canadian students. Although the
levels of toxicants are lower in aerosol from vaping products compared to tobacco smoke, longterm exposure to e-cigarette vaping may lead to nicotine dependence and an increase in
respiratory and cardiovascular health effects (Herbert et al., 2014). In addition, though vaping
has shown to assist with smoking cessation in adult tobacco smokers (Statistics Canada, 2020),
there is evidence among young adults that vaping is a “gateway” behaviour to tobacco smoking
(Chatterjee et al., 2016).
The literature on the short-term health consequences of vaping behaviour continues to
mount (Statistics Canada, 2020); however, the most effective means of limiting vaping
behaviour, remains unclear. As the vaping market continues to evolve rapidly in North America,
owed to the JUUL e-cigarettes and similar vaping products, research identifying effective health
behaviour change strategies are becoming increasingly paramount.

1.1 History of Electronic Cigarettes
The first e-cigarette was invented by Herbert A. Gilbert, an engineer who came up with
the idea of vaping in 1963 and brought its patent into fruition two years later in 1965. As the
issues of cigarette smoking began to perpetuate itself into the narrative of healthy living the
innovation by Mr. Gilbert grew in popularity and it was quickly sought out as a solution to
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replace burning tobacco and paper with heated, moist, flavoured air (White, 2018). Patented a
year after the U.S. Surgeon General’s “Smoking and Health” report linking cigarettes to lung
cancer and other diseases, Mr. Gilbert touted the device’s tremendous potential in preventing
disease and death from tobacco use, and even promoted it for weight loss (Dunworth, 2020).
Despite Mr. Gilbert filing a patent for his invention called “smokeless non-tobacco cigarette” in
1965, it was not commercialized, and tobacco companies were not admitted introducing ecigarettes to the market (Gilbert, 1965).
It wasn’t until 2003 when a Chinese pharmacist, Hon Lik, reinvented the modern ecigarette to aid in smoking cessation following the death of his father from lung cancer
(Hammond et al., 2019). Since then, a Chinese electronic company, Ruyan, sold e-cigarettes over
the Internet and has exported them internationally, receiving the e-cigarette and e-liquid patent in
2007 and introducing the modernized vaping device to North America and Europe in the same
year (Bell & Keane, 2012).

1.2 Description of Electronic Cigarettes
Electronic cigarettes or e-cigarettes are a battery-powered nicotine delivery system that
employs heat to vaporize a liquid nicotine solution without burning tobacco (Goniewicz et al.,
2014). E-cigarettes are known by many different names, sometimes called “e-cigs,” “cig-alikes”, “mods,” “vape pens”, “vapes,” “tank systems,” and “electronic nicotine delivery systems
(ENDS)” (CDC, 2010). The use of e-cigarettes is also commonly referred to as the act of vaping,
defined as “the act of smoking an e-cigarette” by the Oxford Dictionary and recognized as the
word of the year in 2014 (Steinmetz, 2014).
E-cigarettes generally consist of three main components: a cartridge, an atomizer, and a
battery, which may be rechargeable. The use of e-cigarettes involves inhaling at the head of the
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cartridge where a sensor detects when someone is inhaling, sending a signal to a processor that
switches on a heater, known as the atomizer. From there, the atomizer heats up a solution to
produce a vapour that can then be inhaled. As someone draws on the e-cigarette, an LED light is
also switched on by the processor, simulating a flame (Trtchounian et al., 2010). The liquid
within the vape pens, also known as the “e-juice” contains a variety of substances including
nicotine, flavouring chemicals like diacetyl, and certain toxic metals such as lead, chromium, and
nickel (Olmedo et al., 2018).
There is a wide range of liquid flavours available for consumer purchase including fruit,
chocolate, and candy amongst a variety of devices, usually made to resemble pens, USB sticks,
and other everyday items (Worsley et al., 2014). Although not all vaping devices resemble other
e-cigarette devices, such as the tank systems, or “mods” that are much larger devices, all these
products share the common anatomy of the cartridge, atomizer, and battery system with the
average device containing between 0.5 and 24 mg/ml of nicotine (Azagba, 2018).

1.3 Prevalence Among Canadian Populations
1.3.1 Canadian Adolescents
In a survey study by Statistics Canada among Canadians between grades 7 to 12
there has been an increase in the use of vaping products. In the most recent national
survey on Canadian adolescents done in 2018 by Statistics Canada, 34% of students in
grades 7 to 12 had reported having tried a vaping product and 20% reported using them
within the last 30 days. Specifically, 28% had reported having tried an e-cigarette with
nicotine and 29% had tried an e-cigarette without nicotine. Among this population
sample, 18% of students had reported using an e-cigarette with nicotine and 11% had
used an e-cigarette without nicotine in the past 30 days (Canada, 2021). In this survey,
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most students who had reported having tried a vaping product had also tried a cigarette.
The increase in vaping usage in Canada is significantly attributed to its accessibility with
54% of all students thinking it would be either “fairly easy” or “very easy” to get an ecigarette with nicotine if they wanted one, and 58% thought it would be “fairly easy” or
“very easy” to get an e-cigarette without nicotine if attempted (Canada, 2021).
Moreover, Cole et al., (2020) found that, from 2013-2019, accounting for
variability across provinces, the prevalence of e-cigarette ever and current use increased
over time across Canada, particularly between 2016-2019. Specifically in Ontario, the
prevalence of ever and current e-cigarette use increased among all grades, genders, and
ethnicities. In contrast, the prevalence of current cigarette smoking remained relatively
stable over the study period. Consistent with data from the United States, the prevalence
of e-cigarette use among an adolescent sample of Canadian youth has increased
substantially in a short period of time (Cole et al., 2020).
Similarly, Hammond et al., (2016) assessed the prevalence of e-cigarette use
among Canadian students in grades 7 to 9 in 2016 and among Canadian’s aged 15 and
older in 2017, respectively (Hammond et al., 2017). Among adolescents in grades 7 to 9,
12.6% of Canadian students reported having tried an e-cigarette with 5.4% having used
an e-cigarette in the past 30 days. Among this population sample, two-thirds of current
smokers in grades 7 to 9 had used an e-cigarette in the past 30 days, compared to
approximately 5% of non-smokers. Within this study, e-cigarette varied by province:
prevalence was lowest in Ontario and highest in Nova Scotia (Hammond et al., 2016).
Subsequently, among a population survey of Canadian’s aged 15 and older, 15.4%
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reported having ever tried an e-cigarette with 2.9% having used one in the past 30 days
(Hammond et al., 2017).
In addition, Hammond et al., (2020) surveyed a sample of 16 to 19-year old’s,
assessing the use of vaping and smoking devices across Canada, United States, and
England. The study showed that the number of Canadians in high school, aged 16 to 19
years, who have tried vaping was up from 29.3% in 2017 to 40.6% in 2019. It also
showed a 112% increase in adolescent vaping over a two-year period: from 8.4% in 2017
up to 17.8% in 2019. Hammond’s study also measured youth vaping trends in the United
States and England, demonstrating a similar increase to Canadian teens in America from
11.1% in 2017 up to 18.5% in 2019. Whereas in England, there was a smaller increase
from 8.7% in 2017 up to 12.6% in 2019, with a lower youth vaping prevalence of 12.6%
when compared with both Canada (17.8%) and the United States (18.5%) (Hammond et
al., 2020).

1.3.2 Canadian Youth and Young Adults
Among Canadians between the ages of 15 to 24 there has been an increase in the
use of vaping products since 2009 (Statistics Canada, 2020). In the most recent national
Canadian Tobacco and Nicotine Survey done in 2020 by Statistics Canada, 14% of
Canadian youth (15 to 19) have reported to having tried a vaping product and young
adults (20 to 24) age groups having the highest rates of trying vaping compared to adults
25 years and older at 43%. Among Canadian youth and young adult populations who
self-reported as having vaped in the past 30 days, 65% were current smokers, 20% were
former smokers, and 15% had never smoked cigarettes. Of this population sample, 32%
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of current or former cigarette smokers who had never used vaping products reported
using it as a quit-smoking aid (Statistics Canada, 2020).
Fataar and Hammond (2019) conducted an international Youth Tobacco and
Vaping Survey to account for socio-demographic, vaping and smoking, cannabis, and
cannabis vaper misclassification measures in Canada, England, and the United States.
Online surveys conducted over a two-month period in 2018 found that e-cigarettes have
emerged as the most common mode of nicotine delivery among youth across Canada and
the U.S., whereas smoking remains the dominant form of delivery for cannabis. Within
the data collected in their 2018 survey, Canadian youth reported 37.3% ever vaping ecigarettes (the highest in relation to the three countries involved in the survey study) and
14.6% reported having vaped in the past 30 days (the second highest) (Fataar &
Hammond, 2019).
Moreover, Czoli et al., (2014) examined the prevalence and perceptions of ecigarette use among Canadian youth and young adults through online self-report
questionnaires. Within a sample of over 1000 youth and young adults, 16.1% reported
trying an e-cigarette (5.2% non-smokers, 18.9% former smokers, and 34.5% current
smokers), and 5.7% reported use in the past 30 days. Compared to non-smokers, former
smokers and current smokers were more likely to have tried e-cigarettes, and current
smokers were more likely to have tried e-cigarettes than former smokers. An important
distinction within this 2014 study is that close to half of respondents (43.4%) had seen ecigarettes advertised for sale, highlighting the high commercial awareness of e-cigarettes
among this population age (Czoli et al., 2014).

1.3.3 Canadian Adults
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According to Health Canada, there continues to be a generational difference in the
use of vaping devices (Canada, 2021). As the increase in popularity of vaping devices
among Canadian adolescents, youth, and young adults has grown over the past decade,
the proportion of adults aged 25 and older have reported a significantly lower rate of
consumption. In comparison, the 2020 Canadian Tobacco and Nicotine Survey revealed
only 13% of adults indicated that they had tried vaping at some point and 3% of adults
reported using a vaping product in the past 30 days. Across all age groups who reported
having using a vaping product within the past 30 days, 14% reported that they vaped on a
daily basis, however older Canadians continue to be more likely to report smoking
cigarettes with approximately 1 in 10 Canadians having reported smoking cigarettes on a
regular basis (Statistics Canada, 2020).
In relation to the high rate of Canadian adult smokers, Gravely et al., (2019)
presents statistics on the prevalence estimates of awareness, ever-use, current use, and
daily use of nicotine vaping products from 14 countries among a sample population of
self-reported smokers and recent ex-smokers. Within this sample population, Canadian
adults over the age of 25 who identified as smokers or recent ex-smokers, 99.3% of the
population reported being aware of nicotine vaping products, 62.4% of the population
reported ever-used nicotine vaping products, 12% reported current use of nicotine vaping
products, and 4.4% reported daily use. In comparison to the 14 countries included in this
survey study Canadian adults (although lower prevalence compared to younger Canadian
populations) were among the top three highest percentages of vaping awareness, everuse, and current use; only in daily use of nicotine vaping products do Canadian adults
represent the fourth highest percentage. Although the prevalence of vaping products in
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Canadian adults is the lowest compared to younger age groups, the corroboration
between past cigarette usage and subsequent vaping behaviour in this population is
significant (Gravely et al., 2019).

1.4 Prevalence Among Global Population
As of 2018, 98 countries had national laws regulating e-cigarettes and 29 countries had
banned the sale of e-cigarettes completely (Kasza et al., 2018). Currently, 41 million people
around the world are estimated to use e-cigarettes or “heat-not-burn” tobacco products (WHO,
2020). Although the global market for e-cigarettes is still small relative to tobacco cigarettes, it
continues to grow rapidly (WHO, 2019). In 2020, worldwide sales of tobacco reached more than
$713 billion, compared to $15.7 billion for e-cigarettes. At this current rate of product growth,
the sales of vaping products are projected to more than double to $40 billion by 2023, while
cigarette sales are expected to decline slightly (WHO, 2019). While research data are
accumulating on the adverse biological effects of e-cigarette use (Tommasi et al., 2019), focus is
also being shifted to the efficacy of vaping combined with behavioural therapy in helping
smokers quit (Jackson et al., 2021). The existing data clearly show that vaping is not risk free
and together with the growing concern that vaping may lead to nicotine addiction and smoking,
especially among youth, international public health agencies are determined to investigate the
health risks and profile of vaping (Besaratinia & Tommasi, 2019).

1.4.1 North America and Europe
The most recent survey on the global prevalence of vaping show that the three
largest markets for vaping products are the United States, the United Kingdom, and
Canada, respectively (Statista, 2020). Similar to the Canadian population statistics, youth
and young adult populations are the highest reported users of e-cigarettes (The New
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England Journal of Medicine, 2019) with 20% of Americans aged 18 to 29 using vaping
products, compared with 16% of those aged 30 to 64, and fewer than 0.5% among those
65 an older (Newport, 2021). As the second largest market in the world for e-cigarette
products worth £2.3 billion (Statista, 2020), the United Kingdom has seen the highest
vaping market growth in Europe where there are an estimated 2.8 million e-cigarette
users. This number represents a four-fold increase from 2012, when there were only
700,000 vape users in the country (Cohen, 2017). However, in opposition to the
demographic evidence correlating population age with the highest vaping prevalence, the
age range reporting the highest presence of vapers is 35 to 44 years (Statista, 2019). It is
important to note that among the three countries of highest reported vaping prevalence
globally, the UK holds the highest prevalence of cigarette smokers (19.5%) (WHO, 2021)
with the most common reason for vaping being to use e-cigarettes as an aid to quit
smoking (22%) (Statista, 2019).

1.4.2 Rest of the World
The amount of e-cigarette users varies by country. Although the United States,
United Kingdom, and Canada currently hold the highest prevalence of vaping, other
countries around the world are continuing to see an increase in its usage (Staff, 2018). In
Russia, the National Tobacco Control Law and Monitoring and Evaluation Survey found
that 11.9% of the population had tried e-cigarettes and 25.8% of those self-reported as
regular users (Gambaryan, 2018). In France, another European country with significant ecigarette usage, a recent national survey conducted by France’s Monitoring Center for
Drugs and Drug Addiction showed about 10% of the French population use e-cigarettes
regularly (Trenda, 2020). Asia is the most populous continent on the planet with 4.15
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billion inhabitants: over four times the population of Africa (Cohen, 2017). As a result,
although the penetration density is higher in other regions like the U.S., Asia hosts more
e-cigarette users than any other continent (Cohen, 2017) with the largest vaping market
being in Malaysia, currently, with an estimated one million e-cigarette users (3.1%)
(Palipudi et al., 2015).
In China, where the e-cigarette devices were first commercially successful,
ironically, has a very small vaping community of approximately 1% (equate to over 13
million e-cigarette users) (Zhao et al., 2020). Outside of North America, Europe, and
Asia, the usage of e-cigarettes is not prominent (Cohen, 2017). According to the
Australian Institute of Health and Welfare, although the number of Australians vaping
has doubled since 2016, only 2.5% of Australians were currently vaping (Ven et al.,
2020). The usage of e-cigarettes in Africa is relatively unknown. For most of Africa, it
can be assumed that there is no major vaping presence, however, in the country of South
Africa, vaping has gained some momentum with an estimated 200,000 e-cigarette users
(Cohen, 2017). South America also has an extremely small vaping and e-cigarette
presence (Statista, 2020). This may be in large part due to the tremendous level of
restriction and regulation on vaping throughout most of South America’s most populous
countries. These include the banning of sale and import of e-cigarettes in Argentina
(Morello et al., 2016), the banning of the manufacturing and sale of e-cigarettes in Brazil
(WHO, 2014), and the banning of sale of vaping devices completely in Uruguay (Cohen,
2017).
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1.4.3 Global Trend
In 2011, there were seven million e-cigarette users worldwide. By 2020, that
number had increased to 41 million (WHO, 2020) and it is expected to reach 55 million
by the end of 2021 (Euromonitor, 2020). With worldwide vaping sales reaching $15.7
billion in 2019 the global e-cigarette and vape market size is expected to expand to reach
$40 billion by 2023 (Medicine, 2020) and see an increase of a revenue-based Compound
Annual Growth Rate (CAGR) of 23.8% from 2020 to 2027 worldwide (Wood, 2021).

1.5 Health Effects of E-Cigarettes
In January 2018, the National Academies of Science, Engineering and Medicine (2018)
released a consensus study report that reviewed over 800 different studies; that report made
clear: using e-cigarettes causes health risks. This report concluded that e-cigarettes both contain
and emit a number of potentially toxic substances and carcinogens. The two primary ingredients
found in e-cigarettes, propylene glycol and vegetable glycerin, are both toxic to human cells and
as the products have evolved in variety, the addition of possibly toxic ingredients have only
increased (Sassano et al., 2018). In recent years, there have been an increasing number of studies
that demonstrate that vaping has both short and medium-term effects on the heart and lungs
(Vindhyal et al., 2019), however, the long-term effects of vaping are still unknown as it is a
relatively new activity and the development of some diseases, such as cancer, can take many
years to develop (Xie et al., 2020). It is important to note however that previous literature has
shown vapours from e-cigarettes can damage human DNA, which is a pathway to developing
cancer (Boakye et al., 2020).
Modern e-cigarettes produce several dangerous chemicals including acetaldehyde,
acrolein, and formaldehyde. These aldehydes are known chemicals leading to possible lung
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disease, as well as cardiovascular disease (Ogunwale et al., 2017). E-cigarettes also contain
acrolein, a herbicide primarily used to kill weeds and may potentially lead to acute lung injury,
COPD, asthma, and lung cancer (Bein et al., 2011). In a recent study following a large
population (N = 21,000) over a period of five years starting in 2013, comparing the development
of chronic respiratory disease between people who vaped and those who never used e-cigarettes,
those who vaped were 30% more likely to develop asthma and 60% more likely to develop
chronic obstructive pulmonary disease (COPD) (Xie et al., 2020). It was also recognized that in
humans, just five minutes of vaping can cause changes in the way the lungs work and can lead to
increased inflammation, risk of lipoid pneumonia (Gay et al., 2020) and even a spontaneous
pneumothorax (Skertich et al., 2019).
In a study on e-cigarettes linked to heart attacks and coronary artery disease, Napoli et al.,
(2019) found that compared with non-users, those who vaped were 34% more likely to have a
heart attack, 25% more likely to have coronary artery disease, and 55% more likely to suffer
from depression or anxiety (Napoli et al., 2019). In addition, Peruzzi et al., (2020) found that ecigarettes usage adversely affected blood pressure management, causing tachycardia, and
worsening arterial stiffness. Moreover, within this study, e-cigarette use was found to be
associated with an increased risk of adverse clinical events, including atrial fibrillation and
myocardial infarction (Peruzzi et al., 2020). In addition to physiological health risks, the repeated
use of e-cigarettes containing nicotine increases the risk of addiction, mood disorders, and
permanent lowering of impulse control, even effecting the parts of the brain that control attention
and learning (U.S. Department of Health and Human Services, 2016), leaving the prominent
population demographic of vapers in Canada extremely vulnerable to poor psychological
development.

13

The existence of health risks associated with the use of e-cigarettes is unquestionable,
however, the level of health risk and the health outcomes of vaping cessation associated with ecigarettes remains contentious (McRobbie, 2016). Although we are aware of the potential short
and medium-term health risks associated with vaping on pulmonary and coronary artery disease,
the long-term health effects remain unclear. In addition, there is no evidence to support that
vaping cessation is related to positive health outcome. Similar to tobacco and cigarettes in the
past, it may take several decades for us to truly understand what the extent of harm of these
products are and how reducing their behaviour can affect the individual. It is important to note,
however, that the contemporary evidence suggests e-cigarette may follow the trend of cigarettes
by being related to multiple long-term health risks with continued use (Callahan-Lyon, 2014).

1.6 E-Cigarettes as a Cessation Tool
E-cigarettes are successfully marketed and commonly used in attempts to stop smoking
(Hajek et al., 2019), but evidence is limited regarding their effectiveness as compared with that
of nicotine products approved as smoking-cessation treatments (Siegel et al., 2011). Overall, to
reduce the burden of tobacco-related illness, the best solution for cigarette smoking is complete
cessation (Burch & Ciapponi, 2019). Experts agree that complete tobacco cessation over the long
term, rather than reducing the number of cigarettes smoked per day, is the most effective way to
reduce risk for disease and premature death (Hajek et al., 2019). However, because of the highly
addictive nature of nicotine-based products like cigarettes, cessation tools are recommended
when attempting to quit the habit (Silagy et al., 1994). In Canada, tools like nicotine replacement
therapy (NRT), quit medications/pharmaceuticals and/or counselling are recommended (Hajek et
al., 2019). There is sufficient evidence to support that NRT through skin and mouth (the patch
and gum) is effective to aid smokers in quitting (Prapavessis et al., 2016). NRT through vapour
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may also be more effective as the nicotine delivery is more efficient than the patch or gum, and it
stimulates the smoking experience (Silver et al., 2016).
As e-cigarettes grow in popularity (Zhao et a., 2020), an increasing number of smokers
are using e-cigarettes as a cessation device; however, the effectiveness as a cessation tool at the
population level is still relatively unknown (Maglia et al., 2017). Research is divided on whether
e-cigarettes can be considered a useful smoking device. This lack of consensus is partly due to
the rapidly evolving technology and lack of standardization in the e-cigarette product market,
making it challenging to compare results across studies (Jackson et al., 2021). Some research
shows e-cigarettes can be useful to quit smoking behaviour, while other research shows that
smokers are unsatisfied with the e-cigarette devices and return to smoking cigarettes or maintain
dual use of e-cigarettes and conventional cigarettes (Pechacek et al., 2016).
A recent randomized trial among 886 conventional cigarette smokers in the United
Kingdom found that those who used an e-cigarette starter pack as a nicotine-replacement product
compared to NRT patches and gum reported greater declines in the incidence of cough and
phlegm with more frequent throat and mouth irritation, with no significant between-group
differences in the incidence of wheezing or shortness of breath (Hajek et al., 2019). In another
study examining the effectiveness of e-cigarettes for smoking cessation during a 2-week period
using a cross-sectional online survey, the primary findings were that a large percentage of
respondents reported a reduction in the number of cigarettes they smoked (66.8%) and almost
half reported abstinence from smoking for a period of time (48.8%) (Siegel et al., 2011). These
findings suggest that e-cigarettes may hold promise as a smoking-cessation method, however,
conflicting research surrounding the risks and benefits of e-cigarettes elicit the need for further
investigation to fully understand these devices and their health-impact.
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1.7 Framework Underlying Intervention
1.7.1 Protection Motivation Theory
The Protection Motivation Theory (PMT) is one of a broader category of theories
known as ‘social cognition models’, along with the Theory of Planned Behaviour (Ajzen,
1991) and the Health Belief Model (Rosenstock (1974). Social cognition models propose
that modifiable beliefs (such as attitude, perceived risk, and personal control) function as
predictors of people’s intentions to act (Webb et al., 2010). In turn, intentions are
considered to determine behaviour directly (Webb & Sheeran, 2005). It is proposed
through PMT that people are motivated to react in a self-protective way towards a
perceived health threat based on seven factors: the perceived severity of a threatening
event (PS), the perceived probability of the occurrence, or vulnerability (PV), the
perceived potential intrinsic and extrinsic rewards, the perceived efficacy of the
recommended preventative behaviour (RE), the perceived self-efficacy (SE), and the
perceived response cost (Rogers, 1975). In the modified PMT framework, response-cost
and intrinsic and extrinsic rewards are nulled, including only the PS; PV (Threat) and RE;
SE (Coping) appraisals for assessment (Gaston & Prapavessis, 2009).
The modified PMT model is summarized in Figure 1, in which the four PMT
constructs predict behaviour intention, which then predict behaviour.
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Figure 1 Conceptual model of the Protection Motivation Theory

1.7.2 Threat Appraisal Applications
The threat appraisal pathway involves comparing perceived rewards (intrinsic and
extrinsic) of a maladaptive health-related behaviour (e.g., smoking) with perceived
threats (severity and vulnerability) that the behaviour poses. For example, adolescents
might weigh feelings of relaxation and better concentration (potential perceived intrinsic
rewards of smoking) and beliefs that happier and more popular individuals smoke
(potential perceived extrinsic rewards of smoking), against their knowledge that smoking
causes cancer and other diseases (potential severity of smoking-related risk) with
concerns that smoking may lead to an earlier death (potential vulnerability to smokingrelated risk) (Boer & Seydel, 1996). In addition, Ben-Ahron et al., 1995) showed that
high-risk drinkers perceived problems related to binge drinking to be less severe than
low-risk drinkers and were less likely to intend to drink at safe limits in the future (i.e.,
had lower protection motivation). Similar findings have also been reported in relation to
smoking (Pechmann et al., 1993). Using PMT to code the content of 194 antismoking
advertisements, they found the intention to smoke was reduced with increased health
risks associated with smoking, influenced by increasing the perceived severity of the
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health effect (Webb et al., 2010). Supported by social cognition models, parsimonious
sets of modifiable beliefs (such as attitude and perceived risk) are proven predictors of
peoples’ intentions to act because of the apparent threat on individual health outcome
(Conner & Norman, 2005). Presently, no research has examined whether these threat
appraisal components can be manipulated (enhanced) to increase goal intentions to vape
less among regular vapers.

1.7.3 Coping Appraisal Applications
The coping appraisal pathway involves comparing coping efficacy (self-efficacy
and response efficacy) of an adaptive variant of the health-related behavior (e.g.,
avoiding smoking) with perceived response costs of such adaptive behavior. For
example, adolescents might consider the health benefits that non-smokers may enjoy
(perceived response efficacy of not smoking) and how well they think they could decline
a cigarette offered by a friend (self-efficacy for not smoking), as compared with their
concerns about social isolation if they do not smoke (perceived cost of not smoking)
(Yan, 2014). However, as vaping is a relatively new smoking behaviour, there is no
literature to suggest that reducing/quitting vaping provides health benefits or reduces
health costs. This in turn weakens the self-efficacy constructs (i.e., one can have a high
degree of confidence to reduce or quit vaping, without knowing the response efficacy of
such a behaviour). As a result, these coping appraisal constructs were not considered in
the design of the present study.

1.8

Purpose
The aim of this two-arm randomized trial with repeated measures (i.e., baseline, post-

treatment, and 6-week follow-up) was to investigate whether the use of an 8-minute
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informational video, following the threat appraisal components (i.e., perceived vulnerability and
perceived severity) of the Protection Motivation Theory (PMT) framework, reduces vaping
intention and behaviour in Canadian university students. Another aim was to determine whether
perceived vulnerability and perceived severity are associated with goal intentions to reduce
vaping, and whether goals intentions to reduce vaping are associated with actual reductions in
vaping use.

1.9

Study Hypotheses
1.9.1 Hypothesis I
Those exposed to the threat appraisal information grounded in the PMT
components of severity and vulnerability will score higher on purpose-built questions
reflecting these components than their attentional information control counterparts.

1.9.2 Hypothesis II
Those exposed to the threat appraisal information grounded in the PMT
components of severity and vulnerability will show lower intentions to vape and lower
vaping use compared to their attentional information (nutrition and lifestyle information
group) control counterpart.

1.9.3 Hypothesis III
Increases in both severity and vulnerability of vaping usage will be associated
with a reduction in intentions to vape. Furthermore, reduction in intentions to vaping will
be associated with lower vaping use.
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Figure 2 Flow diagram of study procedures

1.10 Significance
Understanding the specific role perceived vulnerability and perceived severity play in
affecting health behaviour change will help public health educators understand how to develop
specific interventions to inform this population about the negative health effects associated with
e-cigarettes and affect positive change in the decision-making related to vaping.
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Chapter 2
2

Literature Review
No studies have examined the effects of the threat appraisal components (PV and PS) of

Protection Motivation theory on an individual’s concurrent intention and vaping behaviour. Past
literature surrounding PMT has largely focused on traditional tobacco smoking devices such as
conventional cigarette smoking or a hookah in addition to behaviour change interventions related
to physical activity and sedentary behaviour. As we are the first to incorporate the PMT threat
appraisal framework with vaping, studies involving conventional cigarettes are the closest
comparison of recreational behaviour.
Two studies, however, used the PMT framework to examine the effect of genetic risk
information for smoking addiction (Smerecnik et al., 2011; Wright et al., 2006), one study
examined the predictive factors for preventing hookah smoking in the youth of Sirjan city, Iran
based on the Protection Motivation Theory (Sadeghi et al., 2019), four studies examined the
application of the PMT in predicting cigarette smoking behaviour and quitting intention related
outcomes (Lin & Chang, 2021; Chalermrueangrong & Preechawong, 2019; Wu et al., 2014 Yan
et al., 2014; Thrul et al., 2013), and one study examined the relationship between adolescent drug
use intention and protection motivation (Wu et al., 2014). Four of these studies have also focused
on adolescent and young adult populations (Sadeghi et al., 2019; Wu et al., 2016; Yan et al.,
2014; Thrul et al., 2013). Their results can, therefore, indicate what effects the Protection
Motivation Theory may have on population intention to predict maladaptive behaviours (i.e.,
smoking).
As no studies have examined the effects of the threat appraisal applications of PMT
alone, on vaping intention and behaviour, studies that have examined the effects of PMT on
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conventional cigarette smoking and other smoking devices (i.e., tobacco hookah) may be used to
indicate what effects PMT has on predicting intention and behaviour of general smoking devices,
with the appraisal of the health threat and coping responses (Sadeghi et al., 2019).

2.1 PMT and Genetic Risk Information for Smoking Addiction
2.1.1 “Are Smokers Interested in Genetic Testing for Smoking
Addiction? A Socio-cognitive Approach”
This study examined whether smokers are interested in undergoing a genetic test
to identify their genetic susceptibility to nicotine addiction (Smerecnik et al., 2011). In
addition, they aimed to identify socio-cognitive determinants of smokers’ intention to
undergo genetic testing. Following the Protection Motivation Theory, they assessed the
following constructs using an online survey among 587 smokers: threat appraisal (i.e.,
susceptibility and severity), fear, coping appraisal (i.e., response efficacy and selfefficacy, response costs and intention). In addition, knowledge, social norms, and
information-seeking behaviour were measured. Susceptibility and Severity were
measured using two separate sets of four items to measure susceptibility and severity
factors while fear was assessed using three items combined to measure the fear factor.
Response efficacy and self-efficacy were assessed using two separate sets of six items
while response costs were assessed with three items. Protection motivation was
operationalised to undergo a genetic test and was assessed using four items combined to
form the intention factor.
Based on conventional categorisation, 372 smokers (63.4%) were classified as
having a low level of addiction and the remaining 215 smokers (36.6%) were classified
as having a high level of addiction to nicotine. Smokers with a high level of addiction
reported higher intentions to undergo genetic testing (M = 2.70, SD = 0.95) than smokers
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with a low level of addiction (M = 42.50, SD = 41.00), F(1,585) = 5.65, p = 0.02.
Women reported higher intentions to undergo genetic testing than men (M = 2.63, SD =
0.91 vs. M = 2.52, SD = 1.06, respectively), F(1,585) = 4.13, p = 0.04. Smokers between
the ages of 40 and 64 reported higher intentions to undergo genetic testing (M = 2.70, SD
= 0.98) compared to smokers between the ages of 20 and 39 (M = 2.35, SD = 0.94, p <
0.001). No difference was observed between smokers between the ages of 20 and 39,
above the age of 65 (M = 2.59, SD = 1.05), between the ages of 40 and 64, and above the
age of 65 (p’s > 0.26). No differences in intention were observed for level of education,
F(2, 584) = 0.16, p = 0.86. Based on the correlations between the constructs and the
predictions from the PMT, the study found that threat (β = 0.46, p < 0.005) and coping
appraisal (β = 0.36, p < 0.005), both contributed to the intention to undergo genetic
testing for smoking addiction. In addition, fear had a negative impact on this intention,
suggesting that the more people fear the outcome of the genetic test, the less they intend
to undergo such a test. Contrary to the predictions of the PMT, response costs did not
significantly influence the intention to undergo genetic testing nor did knowledge (β =
0.03, p > 0.05) and social influence (β = 0.01, p > 0.05). The intention to undergo genetic
testing significantly influenced information-seeking behaviour (β = 0.18, p < 0.0001).
The more smokers intended to undergo genetic testing, the more likely they were to take
action and click on links containing more detailed information on ‘the working
mechanisms of a genetic test’, ‘the genetic background of smoking’ and ‘the influence of
genetic differences on smoking cessation treatments.
Smokers with low level addiction, that are male, below the age of 39 and above
the age of 65 were observed to be less interested in undergoing genetic testing,
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suggesting that these groups require more attention. The result from the structural
equation modelling analysis suggests that attention should focus on perceived
susceptibility, severity, fear, response efficacy and self-efficacy to educate and inform
smokers about the value of genetically tailored smoking cessation treatments.

2.1.2 “Can Genetic Risk Information Enhance Motivation for Smoking
Cessation? An Analogue Study”
This study explored whether the impact of type of genetic risk information was
moderated by smoker’s self-efficacy (SE) levels (Wright et al., 2006). Key outcomes
were intention to quit and intention to attend an information session about quitting. Using
a three-group, between-subjects design, the risk status manipulation was achieved using
three different vignettes: gene positive, gene negative, or no testing. Participants (n =
198) were adults aged 18 to 25 that self-reported as smoking at least one cigarette every
day. Consented participants were sequentially allocated to one of the three types of
vignettes. Immediately after reading the vignette, the participants completed the postmanipulation questionnaire then were debriefed. Pre-message perceptions of
susceptibility were assessed with a questionnaire purporting to address young adults’
concerns about different health risks, including diabetes, asthma, brittle bones, arthritis,
and heart disease. Fear in response to the message was assessed with six items, “How
tense/anxious/nervous/frightened/uncomfortable/worried did the information about your
chances of getting heart disease make you feel?” Perceived severity of heart disease
included four items (i.e., “Heart disease is a very severe illness”). Response efficacy
included five items (i.e., Stopping smoking can reduce my risk of heart disease”). Selfefficacy for quitting smoking was assessed by using three items (i.e., How confident are
you that you can stop smoking in the next month”). Intentions to quit smoking were
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assessed by using three items (“I plan to stop smoking in the next month”) while
intentions to obtain more information about quitting was assessed by telling participants
that the experimenters were planning to hold information sessions and asking their
intentions to attend the session with two items (i.e., How likely would you be to attend
this session?”). Information derogation was assessed using four items (i.e., “The
information about the risks of heart disease and smoking was over the top”) and threat
minimization was assessed with two items (i.e., “Although I smoke, I do many other
things that lower my chances of getting heart disease”).
Following analysis, the study showed that the gene-positive group was not
statistically different from zero (β = 0.13, p = 0.41). For the gene-negative group,
intentions significantly decreased with increasing self-efficacy (β = -.34, p = .03). The
same was true for the no-testing group (β = -0.31, p = .01). For threat minimization, the
study revealed a significant interaction between risk and self-efficacy. However, instead
of threat minimization decreasing as self-efficacy increased for the gene-positive group,
as predicted, the slope was flat and not significant (β = 0.05, p = .70). In addition, threat
minimization was affected by self-efficacy for the no-testing group, showing a positive
and significant slope (β = 0.45, p < 0.001). Therefore, smokers in the no-testing group
had higher threat minimization scores when they had higher self-efficacy.
These findings suggest that genetic risk information has the potential to motivate
quitting but that coping appraisals, such as self-efficacy perceptions, also need to be
considered. Smokers who received personalized genetic-positive risk information, had
higher intentions to quit than smokers in the no-testing group, who received nonpersonalized risk information derived solely from their smoking status. However,
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stronger intentions to quit were also associated with higher levels of self-efficacy,
regardless of what type of risk information the smokers received. Self-efficacy was
slightly more strongly associated with intentions to quit than was risk. Therefore, to
capitalize on the motivational impact of gene-positive risk information, practitioners may
also wish to consider ways of increasing smokers perceived self-efficacy. Receiving a
gene-negative test result was no more or less motivating than receiving a risk estimate
derived from one’s status as a smoker. Although these findings did not follow the
predictions of PMT, they could be explained by the notion that receiving a higher risk
result from genetic testing creates a “teachable moment” (McBride, Emmons, & Lipkus,
2003) in which smokers are particularly receptive to new information. The presented
implications for using genetic risk information to motivate smoking cessation is an
important direction for future research on health risk and self-efficacy outcomes for
maladaptive behaviours.

2.2 Effects of PMT on Hookah Smoking and Health Promotion
2.2.1 “Predictive Factors for Preventing Hookah Smoking and Health
Promotion Among Young People Based on the Protection
Motivation Theory”
This cross-sectional study examined the predictive factors for preventing hookah
smoking in the youth of Sirjan city, based on the Protection Motivation Theory (Sadeghi
et al., 2019). Data collection consisted of three parts: first, demographic information was
collected, including the association of family and friend’s hookah consumption and the
sources of information about the harms of hookah. Second, eight multiple questions about
knowledge were assessed. Third, 64 questions related to the construct of the PMT were
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administered. The questions related to the PMT were based on a 5-point Likert scale and
participants had to choose from 1 to 5. The structure of the PMT questionnaire included
perceived sensitivity, perceived severity, internal and external rewards, self-efficacy,
response efficacy, response cost, fear, and protection motivation (Sadeghi et al., 2019).
To determine the internal reliability of the questionnaire, 30 individuals were asked to
complete the questionnaire, and a 0.7 or higher Cronbach’s alpha was considered
acceptable. In addition, to examine external reliability, test-retest was done in 2-week
intervals by 30 youth individuals prior to the start of this study.
Participants (n = 280) were predominantly female (55%), 12-24 years of age
(18.06 ± 3.82), lived in Sirjan (≥ 6 months), and had no mental disorders including
depression (determined by self-report and chart review) (Sadeghi et al., 2019). A
regression analysis of the demographic factors on preventing hookah smoking (PHS)
showed that age (β = 0.30, p = 0.001), education level (β =0.23, p = 0.002), paternal
education level (β = 0.18, p = 0.04), maternal education level (β = 0.26, p = 0.003), the
individual’s hookah smoking (β = −0.34, p = 0.006), father’s hookah smoking (β = −0.17,
p = 0.006), and friends’ hookah smoking (β = −0.13, p = 0.026) were significantly related
to the PMT, so that older participants, those with higher education levels, and those who
had parents with higher education levels were more likely to have PHS, but the
individuals who reported self-smoking of hookah, or father’s or friends’ smoking hookah
were negatively related to PHS. The study variables were normal, and a Pearson
correlation showed that there was a strong and significant correlation between perceived
susceptibility, perceived severity, and fear. There were positive correlations between PHS
and perceived susceptibility (r = 0.32, p < 0.001), perceived severity (r = 0.34, p <
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0.001), response efficiency (r = 0.44, p < 0.001), self‐efficacy (r = 0.50, p = 0.001), and
fear (r = 0.47, p = 0.001) but negative correlations with internal and external rewards (r =
−0.12, p < 0.05). Furthermore, the results of this study showed that the threat appraisal
and coping appraisal, predicted more than 10% of PHS variability, in which the role of
coping appraisal was stronger (β = 0.32).
The study findings showed that age, level of education, parental level of
education, current hookah smoking of the participant, and hookah smoking status of
father and friends were the most important influencing factors on PHS. The results of the
Pearson correlation coefficients suggest that if people become aware of the consequences
and harms of hookah smoking on the health of themselves and those around them, with
an emphasis on producing fear of complications, emphasis on self-efficacy, and
effectiveness of the suggested responses, the threat would have a greater chance of being
alleviated. Therefore, in designing educational interventions, emphasis on the threat and
coping appraisals of PMT to cause fear of hookah smoking and harms, is essential to
alleviating maladaptive health threats.

2.3 Effects of PMT on Cigarette Smoking Quitting intention
2.3.1 “Factors Associated with the Quitting Intention Among Chinese
Adults: Application of the Protection Motivation Theory”
This cross-sectional study examined the use of the protection motivation theory
(PMT) in explaining smoker’s quitting intentions among Chinese adults with the goal of
providing valuable evidence to promote theory-guided and culturally appropriate
cessation interventions (Lin & Chang, 2021). Based on previous literature, they identified
four psychological determinants that play an important role in influencing individuals’
threat appraisal: perceived severity, perceived susceptibility, and intrinsic and extrinsic
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rewards. Considering coping appraisal, three determinants were used: response efficacy,
self-efficacy, and response costs (Lin & Chang, 2021). Therefore, their first hypothesis
was that severity and vulnerability to smoking-related threats are positively associated
with quitting intention. Their second hypothesis is that intrinsic and extrinsic rewards and
response costs would be negatively associated with the quitting intention. Their third
hypothesis was that both coping and threat appraisal variables are significant predictors
of the quitting intention. In addition, Lin & Chang (2021) tested the psychological
determinants and the target behaviour simultaneously, predicting the effect of the quitting
intention and PMT constructs on behaviour. Finally, their final hypothesis is that the
smoking intention is a sound variable that can predict quitting behaviour.
Participant (n = 613) were dominantly male (91.7%), 37.94 ± 14.31 (mean ± SD)
years old, daily smokers with ≥1 year of smoking duration, and reported being residents
(≥5 years) of one of 26 randomly selected provinces in Mainland China. Data was
collected using questionnaires administered in the form of face-to-face interviews, lasting
for approximately 15-20 minutes for each participant. The questionnaires were designed
with four sections: sociodemographic information, smoking status, smoking-cessation
information, and PMT constructs (Lin & Chang, 2021). Cronbach’s alpha and interclass
correlation coefficients (ICC) were used to assess the reliability of the individual PMT
constructs and a multiple linear regression was used for multivariable analysis. Stronger
quitting intentions were significantly associated with higher perceived vulnerability
(Coef. = 0.13, p < 0.01), self-efficacy (Coef. = 0.28, p < 0.01), and response efficacy
(Coef. = 0.23, p < 0.01) but inversely associated with intrinsic rewards (Coef. = −0.15, p
< 0.01). Greater quitting intentions were significantly associated with higher threat (Coef.
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= 0.19, p < 0.01) and coping appraisals (Coef. = 0.25, p < 0.01). Regarding behaviour,
longer quitting attempts were significantly associated only with self-efficacy (Coef. =
0.13, p < 0.01) and response cost (Coef. = −0.18, p < 0.01). In summary, their results
confirmed the applicability of PMT for predicting the quitting intention in Chinese adults
and self-efficacy was represented as the only factor that had a predictive effect on both
the intention and behaviour.
The study findings confirmed the applicability of PMT for predicting the quitting
intention among Chinese adults, however, the results of this study provide only partial
support for their hypotheses. This finding is consistent with those reported by other
researchers that not all PMT measures had the same strength in predicting behaviour
(Ruiter et al., 2001). Consistent with their hypotheses, both coping and threat appraisal
exhibited significant predictive values for the quitting intention, suggesting that at least
some of the seven PMT constructs act as stable factors influencing quitting behaviour.
Among the threat appraisal constructs, vulnerability to the health threat was confirmed as
a predictor of the quitting intention, but the severity of the threat was not, even though the
items related to perceived severity had the highest mean score among all the items. A
possible explanation for this ineffective predictive relationship may be that people may
know that smoking is harmful but are not truly motivated to quit. On the other hand, the
higher vulnerability is a sign that smokers realize how they could be influenced by the
negative consequences of smoking behaviour. In addition, the intrinsic rewards were one
of the important predictors for the quitting intention, but extrinsic rewards and response
costs may be less important in influencing behaviour. Moreover, perceived efficacy was
found to be the main predictor of the quitting intention among all four perceptions,
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pointing to the importance of enhancing smokers perceived self-efficacy in quitting
smoking and refusing cigarettes. Overall, the results show that the quitting intention is
significantly associated with quitting behaviour in all models. Self-efficacy and response
cost are significantly related to quitting behaviour; self-efficacy being the only factor that
has a predictive effect on both the intention and behaviour. This finding is consistent with
early research suggesting that coping appraisal, especially self-efficacy within this
construct, is a better predictor of health behaviour than threat appraisal (Thrul et al.,
2013), thus reaffirming that threat communication may be less important for smokingcessation-related health education.

2.3.2 “Effects of the Motivation Program to Quit Smoking in Royal
Thai Air Force Officers with Non-Communicable Disease Risks”
This quasi-experimental study compared the outcome of a smoking cessation
program based on the Protection Motivation Theory and a brief intervention among
Royal Thai Air Force (RTAF) officers, with non-communicable disease (NCD) risks
(Chalermrueangrong & Preechawong, 2019). The purpose of this research was to
compare the outcome of a PMT-based smoking cessation program and a brief
intervention to a control group among RTAF officers with NCD risks. The Fagerström
test for nicotine dependence (FTND), a six-item questionnaire that is widely accepted,
was used to assess the severity of nicotine dependence. The intraclass correlation
coefficient of the Thai version was 0.83 and Cronbach’s α was 0.52 (Chalermrueangrong
& Preechawong, 2019). The “Quit Smoking Questionnaire” (QSQ) was self-reported and
assessed the participant’s smoking status. In addition, a device designed to measure the
amount of exhaled carbon monoxide (CO) in a smoker’s breath was used to verify
smoking cessation. In this study, they used a level of < 8 ppm CO as the abstinence cut
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off (8-10 ppm is commonly indicative of abstinence) (MacLaren et al., 2010). The
program provided the participants with three weekly sessions of one-on-one counseling
lasting 20-30 minutes each. In the first session, the participants were made aware of the
adverse effects of tobacco and the dangers of continuing to smoke by using exhaled CO
measurements from the Smokerlyzer combined with the results of their health report. The
participants were then provided with advice on how to quit smoking by following a
mutually agreed upon action plan. In the second week, the goal was to build up an
expectation of the positive effects of changing behavior to quit smoking and to encourage
the subject’s capability of quitting smoking by using the shared experiences of role
models (other RTAF officers who successfully stopped smoking). The third activity
(eighth week) was the session in which the researcher met the participants individually to
measure their exhaled CO, listen to their experiences and give them advice on how to
cope with nicotine withdrawal and other suggestions on how to sustain abstinence.
Participants (n = 60) were males, between the ages of 21-59 (38.27 ± 10.59), with
a BMI ≥ 25 kg/m2, fasting blood sugar ≥ 100 mg% or blood pressure ≥130/85 mmHg,
smoking at least one cigarette in the past seven days, and able to communicate via mobile
phone. The participants were equally divided into two groups, using group matching by
age and the number of reported cigarettes smoked per day to control for confounding
variables. By the end of the three weekly sessions, only 6 participants in the Motivation
to Quit Smoking Program and one in the control group were able to quit successfully.
The percentage of participants who reported the seven-day point prevalence abstinence
verified by exhaled CO in the experimental group was significantly higher than in the
control group (20.0%; 3.3%; p < 0.05). Although there was no significant difference
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between the two groups at the beginning of the study in the baseline average number of
cigarettes smoked per day, by the end of the study, the numbers of cigarettes per day had
decreased from 12.87 ± 7.23 and 10.53 ± 7.45 at baseline to 7.23 ± 5.90 and 8.83 ± 6.13
in the experimental and control group, respectively. The reduction in the number of
cigarettes smoked per day by participants in the experimental group was significantly
greater than that of the control group (p < 0.05).
The Motivation to Quit Smoking Program was moderately successful in
persuading RTAF officers to stop smoking or at least reduce the number of cigarettes
smoked per day. As the study concluded, the percentage of participants who succeeded in
smoking cessation was found to be significantly higher in the experimental group (p <
0.05) than in the control group. Using RTAF officers who had successfully quit smoking
as role models to share experiences and information as well as to inspire the participants
to quit smoking was considered effective. Using the CO measuring device to determine
the amount of exhaled CO helped participants to see the negative effects of smoking
directly and the danger of cigarettes more clearly and was a strong motivator for quitting
smoking. As most research studies using PMT focus on adolescent and young adult
populations, it is rare to see a study using the constructs of protection and motivation.
Although this study used the constructs of the PMT within its study procedures, the
introspective correlations between threat appraisal and coping appraisal applications were
not assessed. However, the use of PMT among an adult population supports the data that
this application promoted smoking cessation as the experimental group reduced the
number of cigarettes smoked per day from 12.87 to 7.23, while the control group reduced
their cigarettes from 10.53 to 8.83. Using the PMT framework as an intervention to
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promote smoking cessation over three weekly information and counselling sessions, the
research supports the application that providing knowledge and motivation are effective
ways to eliminate the participants’ reluctance to quit and provide a clear goal to achieve
in their smoking cessation plan.

2.3.3 “Application of the Protection Motivation Theory in Predicting
Cigarette Smoking Among Adolescents in China”
This study investigates the role of PMT on perceptions and appraisal pathways
within an integrative system to predict tobacco use intention and behaviour among
adolescents in China, demonstrating the utility of PMT (Yan et al., 2014). Data collection
was conducted in classroom settings using the “Chinese Student Health Behaviour
Questionnaire,” distributed to individual students were randomly selected for
participation among the eligible high schools (n = 35) in Wuhan, China. Participants
completed the questionnaire in approximately 25 to 35 minutes. PMT constructs were
assessed using the PMT Scale for Adolescent Smoking (Macdonell et al., 2013; Yan et
al., 2014).
Participants (n = 553) were equally represented by gender (50%), 16.28 ± 0.98
(mean ± SD) years old with no significant gender differences in grade, parents’ education
level, or family income; parental approval was required before enrollment into study.
Three sets of regression models revealed stronger smoking intentions were significantly
associated with more frequent past-month smoking, smoking more cigarettes per day,
lower vulnerability and severity, higher extrinsic and intrinsic rewards, lower selfefficacy, and higher response cost (Yan et al., 2014). Past month smoking frequency was
associated with PMT constructs in the same manner, and frequency was also significantly
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associated with lower response efficacy of not smoking; the strongest relationships were
among pairs of variables forming perception scores (i.e., r = 0.52 for vulnerability and
severity, r = 0.61 for extrinsic and intrinsic rewards, and r = 0.41 for self-efficacy and
response efficacy. To summarize, the study found that greater perceived intrinsic and
extrinsic rewards, lower perceived threat, and lower self-efficacy were related to more
cigarettes smoked per day, more frequent recent smoking, and higher intention to smoke,
respectively.
These study findings provided new evidence supporting the utility of behavioral
theories developed in the West to advance tobacco research in China and other
developing countries, where 80% of all smokers in the world reside (Giovino et al., 2012;
WHO, 2011). When all the PMT measures were analyzed individually, most PMT
components were significantly related to smoking intention and behavior, but the strength
of the relationships differed for different PMT constructs. This finding implies that
different attention should be directed to the more influential PMT constructs in devising
and delivering behavioral intervention programs to achieve better effects. However,
although it may present a challenge to stress to young adolescents the long-term negative
health impacts of smoking (Smith & Stutts, 2003), we cannot ignore the significance of
this strategy in tobacco use prevention. Specifically, for tobacco use prevention among
adolescents, more attention should be paid to perceived rewards (including intrinsic and
extrinsic rewards) and perceived efficacy (including self-efficacy and response efficacy)
to strengthen the prevention intervention programs for sustainable effects.
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2.3.4 “Adolescents’ Protection Motivation and Smoking Behaviour”
This cluster-randomized controlled trial examines the applicability of the PMT as
a theoretical framework to predict the development of smoking behaviour over the course
of 2.5 months in a sample of German adolescents (Thrul et al., 2013). Participants
completed questionnaires at baseline (T1) and at follow-up (T2) 2.5 months later.
Questionnaires at T1 and T2 were connected using a code (first two letters of first names
of parents) and participants’ age and gender, thus guaranteeing anonymity and
confidentiality. Adolescents participated in a clinic-based emotionally arousing
intervention for tobacco prevention. The authors built on the work of Pechmann et al.,
(2003) to operationalize the constructs in the area of threat appraisal, coping appraisal,
and intentions. Current smokers were determined based on a question within the selfreported smoking behaviour questionnaire and biochemical verification of self-reports
were conducted for a random subsample at baseline (n = 74) and follow-up (n = 72) using
carbon-monoxide breath analysers (BMC 2000 CO Monitor, Senko Co., Ltd, Korea).
Participants (n = 494) were based in 18 German secondary schools from the
southwest region of Germany. Participants were equally represented by gender (50.61%
female), 13.15 ± 0.89 (mean ± SD) years old. Excluded students were either not present
in the classroom on the day of the assessment (n = 154), were current smokers (n = 70),
or gave inconsistent self-reports of their current smoking status (n = 33). Of this sample,
n = 110 (16.3%) were lost to follow-up. A just identified model with zero degrees of
freedom was calculated and revealed a weak to moderate correlation between behavioural
intention (T1) and severity, vulnerability, response-efficacy and response costs, and a
strong correlation between behavioural intention (T1) and self-efficacy. Behavioural
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intention at T2 was weakly to moderately correlated with self-efficacy and weakly
negatively correlated with response costs. Results of the path analysis model revealed
that self-efficacy significantly predicted behaviour intention at T1. Furthermore,
behavioural intention at T1, significantly predicted behavioural intention at T2. No
significant effects of age and gender on any of the outcomes were observed. Self-efficacy
had a significant indirect association with behavioural intention at T2 via behavioural
intention at T1 (β = 0.14, t = 4.1, p < 0.001) and a significant indirect association with
smoking behaviour via behavioural intention at T1 and T2 (β = -0.07, t = -3.7, p < 0.001).
Study findings provide only partial support for the PMT in the context of
adolescent smoking. Contrary to their hypothesis, the threat appraisal constructs of
perceived severity and perceived vulnerability were not able to significantly predict
concurrent or future behavioural intention and future smoking behaviour. On the other
hand, the coping appraisal construct of self-efficacy exhibited some predictive value,
suggesting that self-efficacy is the strongest predictor of concurrent smoking-related
behavioural intention. This suggests that a high confidence of adolescent in their ability
to resist cigarette offers is associated with a high intention to decline any offers.
Furthermore, the results suggest that intentions are somewhat stable over time. Overall,
this study suggests that coping appraisal, specifically self-efficacy within this construct,
is the better predictor of health behaviour compared to threat appraisal; therefore, threat
communication may be less important in influencing this behaviour (Thrul et al., 2013).

2.4 Effects of PMT on Drug Use Intention
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2.4.1 “Correlates of Protection Motivation Theory (PMT) to
Adolescents’ Drug Use Intention
This quantitative cross-sectional exploratory study examined the relationship
between adolescents’ drug use intention, demographic factors, and the protection
motivation level (Wu et al., 2014). Questionnaires (n = 2) were distributed to students in
class; the first contained 22 questions based on the PMT, and the second focused on
general information, including demographics. The differences of the appraisal factors
were between two groups: one with the intention to use drugs (intention group) and one
without it (no-intention group). The PMT questions were measured on a five-point Likert
scale, measuring the seven factors within the PMT framework. In this study, all items
were randomized to minimize the consistency effect (Brace, 2006). The chi-square
test/Fisher exact test and the Mann-Whitney U test were used to compare the intention
and no-intention groups by demographic factors and PMT measures. Demographic
factors with a p-value <0.1 were further related to PMT measures by using binary logistic
regression.
Participants (n = 318) were predominantly male (57.5%), nearly half of them
(151, 47.5%) between 13 and 15 years among a population age sample of below 21. Less
than half of the students (78, 24.5%) had $500 or more available to spend and the
majority had no religious beliefs (211, 66.7%) and lived with both parents (242, 76.1%).
Results of the Chi-square test/Fisher exact test showed that the factors of gender, family
structure, and pocket money were significantly different among students with and without
drug use intention. Results indicated that a significantly higher proportion of female
students had the intention to use drugs (male: 2.7%, female: 8.1%, p < 0.05). Students
living with both parents tended to have a lower intention to use drugs than those living
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with one parent or those not living with parents (living with both parents: 3.3%, one
parent: 10.0%, not living with parents: 12.5%, p < 0.05). Students who had more than
$501 available per month were found to have a higher intention to use drugs. The mean
score for threat appraisal only showed significant difference in perceived severity (p <
0.05). Results of the logistic regression analysis showed that intrinsic and extrinsic
rewards were significant predictors of students’ drug use intention. The corresponding
odds ratios were 2.90 (95% CI = 1.24-6.81, p < 0.05) and 8.04 (95% CI = 2.63-24.56, p <
0.001). The mean score for coping appraisal revealed that the different responses to
efficacy and self-efficacy were statistically significant with p-values smaller than 0.05
and 0.001, respectively. The intention group also reported a higher response cost of 3.63
compared to 3.50 in the no-intention group, but the difference was not significant.
Study findings provide partial support for the PMT that those in the no-intention
group reported significantly higher perceived severity, self-efficacy, and response
efficacy compared to the intention group. Adversely, those in the intention to use drugs
group reported significantly higher extrinsic and intrinsic rewards. The research suggests
that major transitions in the lives of adolescents, like changes in physical development or
social situations, as well as adolescents that identify with living with one parent, having
either high- or low-income households, lower educational attainment, and higher amount
of pocket money were all predictors of greater intention to use drugs. The logistic
regression showed that a very good regression model could be developed using PMT.
This was determined by the high Nagelkerke R2 and the results of the goodness of fit
tests. Particularly, the two significant predictors, intrinsic and extrinsic rewards, could
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serve as a guide for health educators and help design more focused and evidence-based
drug abuse prevention campaigns in school settings (Wu et al., 2014).

2.5 Summary of Relevant Research
The majority of reviewed studies were designed to examine the effect that distinguishable
demographic characteristics along with PMT threat and coping appraisals had on maladaptive
behaviour and intention. Those that were not, examined the effects of a motivational program,
supported by the PMT framework, in absence of intercorrelated variance assessment between
threat and coping appraisals.
Of the studies assessing PMT appraisal variance, threat and coping appraisal outcomes on
intention and behaviour were the most frequently analyzed. Threat appraisal consisted of
perceived vulnerability, perceived severity, intrinsic reward, and extrinsic reward while coping
appraisal incorporated self-efficacy, response efficacy, and response cost (Rogers, 1975).
Various maladaptive behaviours were assessed (i.e., hookah smoke, conventional cigarette, and
drug use) with representation of various age groups (i.e., adolescents, youth, young adults, and
adults) among varying outcome factors attributed to intention and behaviour (i.e., genetic risk,
fear, socio-cognitive determinants, threat information manipulation, coping appraisal
manipulation). Among the studies included, each used the PMT constructs using a scale based on
the seven components of threat and coping appraisal (Smerecnik et al., 2011; Wright et al., 2006;
Sadeghi et al., 2019; Lin & Chang, 2021; Chalermrueangrong & Preechawong, 2019; Yan et al.,
2014; Thrul et al., 2013; Wu et al., 2014). Adding further complexity to intervention, multiple
study designs were included: cross-sectional exploratory, cluster-randomized controlled trial, and
quasi-experimental study.
Despite the differences in maladaptive behaviour, age group, and study design, the
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reviewed studies collectively indicate that using specific PMT constructs can affect intention and
quitting smoking behaviour in the following two ways:
1.

a) The Greater intrinsic and extrinsic reward, the lower the intention to abstain
from behaviour;
b) The Greater perceived severity, the higher the intention to abstain from
behaviour (most effective construct of threat appraisal);
c) The Greater perceived vulnerability, the slightly higher (inconsistent) intention
to abstain from behaviour;
d) The Greater perceived susceptibility, the higher the intention to abstain from
behaviour;
e) The Greater perceived risk, the higher the potential to motivate quitting,
however, coping appraisals, such as self-efficacy perceptions, need to be
considered for optimal affect;

2.

a) The Greater response cost, the lower the intention to abstain from behaviour;
b) The Greater self-efficacy, the higher the intention to abstain from or reduce
behaviour (strongest predictor);
c) The Greater response efficacy, the higher the intention to abstain from or
reduce behaviour;

Variance between threat and coping appraisal outcomes between studies would likely be
attributable to maladaptive behaviour in question and demographic of participants included
within the study design.
It is important to examine the effects of PMT on maladaptive behaviour because the rate
of novel, foreign devices such as e-cigarettes in Canada, are becoming increasingly prevalent
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among teens and young adults (Chadi, 2019). Threat and coping appraisal applications are
theoretically and statistically correlated with intention to abstain from maladaptive behaviour;
self-efficacy and coping appraisals being the strongest predictor for intention and quitting
behaviour because it implies a strong belief in the response behaviour for health benefits and in
the ability and control of vicarious experience in protecting oneself against potentially healththreatening substances, and higher self-ability, to deter temptation or pressure; followed by
perceived severity because the consequences may relate to an anticipated event that may occur in
the future, or to a current state such as a pre-existing health problem, however, research
surrounding the effectiveness of perceived severity remains inconclusive (Jones et al., 2014).

Chapter 3
3

Methods
The study’s protocol and materials underwent full board review and were approved by

the University of Western Ontario’s Health Sciences’ Research Ethics Board in December 2020
(See Appendix A). Recruitment began in January 2021 and continued until data collection
concluded in April 2021, at which point treatment effects on study outcomes were analyzed.
Study design follows the Consort checklist of information for reporting randomised trials
(Consort, 2010). All participants read the Letter of Information (See Appendix A) and provided
informed consent (See Appendix A) prior to participation in the study.

3.1

Recruitment
Participants were recruited through digital posters in university student Facebook groups

and the Mass Email Recruitment system at Western. The student investigator (SI) posted the
study recruitment poster outlining study inclusion criteria, general objectives, and asked potential
participants to email the attached SI email if interested in participating (See Appendix A). The
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mass email posted by Western’s Mass Email Recruitment System followed a general script
providing an overview of the study’s objectives and procedures, eligibility criteria, and contact
information (See Appendix A).
Individuals that expressed an interest in participating were sent a standardized email
containing the ‘Letter of Information’ describing the study objectives and procedures and asked
individuals to email a signed copy of said letter back to the SI (See Figure 3). Individuals that
self-identified as eligible with a signed copy of the ‘Letter of Information’ sent to the SI were
provided the baseline questionnaire links to begin data collection (See Appendix A). Following
baseline assessment, participants that completed the self-reported evaluations within seven days
of contact were provided the next set of questionnaires (T1, T2, T3). For each assessment day, a
reminder was sent to individual participants four days after scheduled completion (See Appendix
B) to notify them to complete that set of questionnaires within the next three days. Those who
failed to submit their self-report questionnaires within the pre-defined seven days were emailed a
notice of exclusion by the SI, informing the participant that their collected data would be
included in the study’s findings, but that they have been removed from further data collection
and subsequent participation in the study (See Appendix B).

3.2

Sample
Prime candidates were current undergraduate students in Canada that planned to reduce

their current vaping habits by expanding their knowledge on vaping products and reflecting on
their own experiences because this intervention would, ideally, support their reduction and
maintenance of vaping cessation. Inclusion and exclusion criteria were enforced to minimize the
confounding effects of extraneous variables on outcomes of interest.
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3.2.1 Eligibility Criteria
Individuals had to be able to read and understand English, over the age of 18
years, current university undergraduate student in Canada, who self-report as current
users of vaping products (>3x in the past 30 days) and intend to adhere to the study
intervention regimen. The language restriction was imposed to assure that participants
provided informed consent, complied with procedure instructions, and appreciate
Figure 3 Flow diagram of recruitment and retention

Note. Number of potential participants reached through Facebook advertisements and the Mass Email Recruitment System
remains uncertain

intervention content. Age and education restrictions were imposed to minimize the effect
that social and environment differences could have on participants’ intention to vape.
Vaping and intention restrictions were imposed to minimize the mediating effect that
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experience, and behaviour differences could have on participants’ affective responses to
intervention details and intention to reduce vaping behaviour.
Participants were excluded from study if they had activity restrictions that would
limit their ability to engage in questionnaire testing, were currently practicing in
behaviour therapy treatment specific to vaping, were under the legal age of 18 at the time
of signing/submitting the consent form or failed to complete and submit completed
questionnaires within the 7-day study timeframe (starting the day that set of surveys is
emailed by the student investigator). Health, function-associated limitations, behaviour
rehabilitations participation, and age restrictions were imposed because these conditions
would have increased individuals’ risk of incurring adverse outcomes following
intervention related to stress, anxiety, and potential psychological distress (Pascoe et al.,
2019). Timeframe restrictions were imposed because they would have influenced relative
anxiety, intention, and behaviour outcomes.

3.2.2 Sample Size
The a priori sample size calculation took into account the large effect size (ηp2 =
.09) obtained by Droulers et al., (2017) and the medium effect size (ηp2 = .05) obtained
by Wright et al., (2008) in their studies combining behaviour health risk information and
intentions to quit smoking. Based on these results, approximately 20-50 participants were
needed per group for a between-group design with a level of .05 and a power of .80
(Cohen, 1992).

3.3

Randomization
Participants were randomly allocated to treatment groups using block randomization and
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a random number generator to place participants in groups of two. This block size was chosen to
increase the likelihood of having an equal number of participants in both treatment groups. We
chose this method of randomization to assign groups equally because it is short enough to
prevent imbalance and long enough to prevent guessing allocation in trials. Block randomization
was implemented for our two-group treatment allocation using a 1:1 ratio with block sizes of
two. Therefore, participants were recruited on a concurrent basis and placed into treatment
groups in blocks of two.

3.4

Instruments
3.4.1 Demographic and Modified Youth Vaping Questionnaires
Two seven-item vaping Canadian student vaping demographic and tobacco use
questionnaires derived from an existing Canadian Student Tobacco, Alcohol, and Drugs
Survey (CSTADS) conducted by a consortium of researchers across Canada, centralized
at the University of Waterloo (2014). Excluding drugs assessment questions, the
Demographic and Youth Vaping Questionnaires collected descriptive information, social
influence, current behaviour, and use of past tobacco-based products. Example items
include “What is your ethnicity?” (Demographic) (See Appendix C) and “Have you ever
used chewing tobacco, cigarettes, cigars, cigarillos, or little cigars?” (YVQ-A) (See
Appendix C).

3.4.2 Modified Protection Motivation Theory Questionnaire
A seventeen-item PMT questionnaire derived from an existing PMT scale for
physical activity measured the two threat appraisals (PV, PS) and two goal intention
items derived from previous PMT and exercise research (Gaston & Prapavessis, 2009).
As previously mentioned, because vaping is a relatively new smoking behaviour and
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there is no literature to suggest that reducing/quitting vaping provides health benefits or
reduces health costs, coping constructs (self-efficacy and response efficacy) were not
implemented. To ensure only true details of known health information is used, only PV
and PS items were tested from the PMT appraisals to measure the effect on vaping
intention.

3.4.2.1

Threat appraisals

PV was assessed by four 10-point items and PS was assessed by four 10point items (0= strongly disagree to 10 = strongly agree), commonly used in the
PMT literature (Courneya & Hellsten, 2001). Example items include, “I feel that
my chance of developing health problems at some point because of vaping is”
(PV; see Appendix C) and “I feel that it would be very serious for me to develop
health problems if I continue to vape” (PS; see Appendix C). The internal
consistency Cronbach’s alpha for this scale for PS was α = 0.88, for PV α = 0.92.

3.4.2.2

Goal Intention

Goal intention was assessed by three 10-point items (0 = Not At All to
10= Very Seriously). An example item is, “Would you seriously consider starting
a structured program designed to help you reduce or quit vaping to decrease your
risk of developing health problems?” (See Appendix C). The internal consistency
Cronbach’s alpha for this scale for intention was α = 0.92.

3.4.2.3

Behaviour

Vaping behaviour was assessed by one 5-point item (0 = 0 times to 5 =
More Than 30). The repeated measure item is “During the past X days, how many
times did you vape?” (See Appendix C).
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3.5

PMT Video Creation
Videos were retrieved from publicly accessible forum channels on YouTube under

“vaping education” and “general health information”, respectively, through the online search tab.
For the PMT intervention video, two separate videos highlighting the severity of vaping on
health and susceptibility of vaping among young adult populations were cut and combined into
one 8-minute video using iMovie on MacOS. For the attention control video, this method was
repeated, instead combining two separate videos focusing on general lifestyle and health
information. Both video links were "Unlisted" (only those with the video link can open the
video) and played through YouTube; group intervention links were emailed to respective
participants (comment sections and "Like/Dislike" buttons on both videos were disabled to
prevent participant interaction).
Participant groups were one of two treatment conditions: PMT present or PMT absent
(attention control). The PMT present group watched an 8-minute informational video (video
link: https://www.youtube.com/watch?v=WTKevKge2dg&t=171s) that explained the current
research and health risks associated with vaping, within the context of a threat appraisal focus
(Perceived Vulnerability and Perceived Severity). During this video intervention, the severity
and vulnerability of vaping among young adults, both the short and long-term health effects were
presented. In addition, the video explained the negative health impacts of vaping and the lack of
research and information that currently exists on popular vaping products, including the
potentially devastating impact it may have on the health of young adult populations. The first
half of the PMT present video included narration by "Science Insider" producer, Benji Jones,
including dialogue regarding the risks associated with vaping by Chief Pediatric Pulmonology at
the NYU Winthrop Hospital, Dr. Melodi Pirzada, and information on nicotine by the Director of
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Pediatric Pulmonology at NYU's Langone Hassenfeld Children's Hospital, Dr. Mikhail
Kazachkov. The second half of the PMT present video included personal experiences and
narratives by students at the University of Utah with information regarding our current
knowledge of vaping health effects through research by Dr. Sean Maddock and Dr. Sean
Callahan from the University of Utah to highlight the susceptibility of vaping for a population of
young adults in university.

3.6

Attention Control Video
The PMT absent group featured an 8-minute nutritional information video (video link:

https://www.youtube.com/watch?v=W4RKlLJU8RM) as an attention control strategy titled
"Health Effects". During this video intervention, the general risks and benefits of nutrition and a
healthy lifestyle were presented. The focus of this video was on how a balanced diet and proper
lifestyle choices (i.e., adequate sleep, diet, etc.) can benefit your life in the short-term and longterm. In the nutrition and lifestyle choices intervention, the topic of substance abuse was
discussed briefly but without depth to illustrate the risks to the health of young adults titled. The
first half of the PMT absent video was presented by the Alliance for Aging Research, including
an immersive video design, explaining the impact that nutrition may have as we age, reviewed
by Dr. Steven Austad and Senior Nutritionist Johanna Dwyer. The second half of the PMT
absent video was presented by TED-Ed with narration by Addison Anderson, including a similar
immersive video design, explaining how the food we eat may affect our brain and overall health.
The nutrition and lifestyle information design were administered as a control because it provides
informative lifestyle choices regarding nutrition that can help promote your overall health
without having an underlying link to vaping behaviour and its subsequent effect on the status of
health. The reasoning behind this is to separate and recognize the impact of threat appraisal
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PMT, compared to general nutrition and lifestyle information on behaviour-intention and actionbehaviour of a Canadian student population.

3.7

Procedures
Participants were recruited on a concurrent basis through poster advertisements on

university student Facebook groups and the Mass Email Recruitment system at Western.
Individuals that self-identified as eligible emailed the student investigator (SI) where the Letter
of Information and Consent was relayed back to the prospective email contact of the individual.
Eligible participants that signed the consent form then emailed the forms back to the SI.
Participants were allocated to one of two experimental groups using a blocked randomization
method; participants were recruited on a concurrent basis and randomized within blocks such
that an equal number are assigned to each treatment. To avoid the presence of stratification errors
we reviewed our allocation design before administering study intervention and purposequestionnaires to prevent participant mismanagement during the protocol (no participant or
researcher blinding was present).
The baseline assessment was comprised of identifiable questionnaires to assess their
history and experience with vaping and measure their intention to vape less, incorporated within
the 4-questionnaire links: Demographic Assessment, Youth Vaping, and PMT (I & II). At Day 7
(T1), participants were emailed their respective video link along with the questionnaires and
were instructed to complete the surveys after watching their videos. The study intervention was a
single site trial delivered as a video link to the email provided by the participant; both
intervention videos were played on YouTube and participants were instructed to complete the
surveys immediately after watching the video attached to the email sent to them. The participants
completed self-reported questionnaires at 3 follow-up periods after baseline in the 6-week
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protocol (all questionnaires were sent by the SI to the email provided by the participants). As
illustrated in Schema 3.3, self-reported vaping behaviour questionnaires were managed at
Baseline, Day 7 (T1), Day 30 (T2), and Day 45 (T3). For every questionnaire set date, the
participants had 7 days to complete that compound of questionnaires. A follow-up "reminder"
email was sent by the SI to the participant emails of those who had failed to submit that set of
questionnaires. The follow-up emails were designed to remind the participants that if they failed
to submit the questionnaires within the following 3 days, they would be withdrawn from the
study. All questionnaire links were created using the Qualtrics Survey Software and were
distributed by the SI to the email provided by the individual participants.

3.8

Data Collection & Storage
Participants were allocated a participant ID (XX-YYY) upon enrollment in the study.

Questionnaires used to collect data were labeled using participants’ ID (See Appendix C), and no
identifiers were associated with participant ID to protect their anonymity. VeraCrypt encryption
software was used to secure participant information on the SI’s laptop and BitLocker-encryption
was used for Personal Vault OneDrive data storage including study data, source data (including
surveys), and Letter of Information and Consent.

3.9

Statistical Analyses
All analyses were conducted using IBM SPSS Statistics 25 for MacOS. All analyses were

by intention-to-treat and included all participants. Missing values (T0, T1...) were replaced using
a multiple imputation analyses methodology and computed separately from completed data
analyses (Jakobsen et al., 2017). Presentation of statistical results and analyses methods for both
completed data and sensitivity data (imputed) are illustrated separately below. Both data sets
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used one-way ANOVAs and chi-square procedures to ensure that there were no systematic
differences between groups on demographic characteristics (See Table 1 and Table 6). Separate 2
(group) by 4 (time) repeated measures ANOVAs were conducted for each of the variable
measures: PV, PS, intention, and behaviour. Pearson correlation analyses were used to measure
the statistical strength and direction of relationship between threat appraisal variables and vaping
intention and behaviour based on the method of covariance (See Table 3). Finally, a linear
regression model was conducted to predict the parameters of threat appraisal on intention and
intention on behaviour variables (See Table 5 and Table 10).

Chapter 4
4

Results

4.1

Group Equivalency
One-way ANOVAs revealed no significant differences indicating systematic differences

between groups with respect to age, F(7, 49) = 1.69, p = .11; in addition, the mean academic year
of the two groups being very similar (3.19 (SD = 1.35) PMT; 3.13 (SD = 1.53) control). No
significant differences emerged (<0.05). Moreover, chi-square analyses indicated no significant
differences between gender χ2 (19, N = 83) = 23.59, p = .22 among the treatment conditions. As
can be seen from Table 1, no significant differences emerged (p < 0.05), indicating that there
were no significant systematic differences between groups with respect to demographic
variables. Therefore, it was deemed unnecessary to use demographic variables as covariates in
the subsequent analyses.
Table 1 Demographic characteristic for the two treatment conditions
Variable

PMT (n = 41)

Control (n = 36)

Statistic (n = 77)

p level

Age in years (SD)

21.58 (3.23)

22.69 (3.70)

F(7, 49) = 1.69

.41
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Academic Year

3.19 (1.35)

3.13 (1.53)

F(4, 59) = 0.49

.74

Male

46.3 %

44.4 %

χ2(19, N = 83) = 23.59

.88

Female

53.7 %

55.6 %

Other

0.0 %

0.0 %

Prefer not to answer

0.0 %

0.0 %

1-5 days

17.2 %

29.2 %

χ2(76, N = 83) = 74.57

.87

5-15 days

38.0 %

33.3 %

16-29 days

17.2 %

20.8 %

All 30 days

27.6 %

16.7 %

Caucasian

61.0 %

50.0 %

χ2(95, N = 83) = 108.0

.42

African American

4.9 %

2.7 %

Hispanic American

2.4 %

5.6 %

Asian American

12.2 %

22.2 %

Indigenous Peoples

12.2 %

5.6 %

Other

7.3 %

13.9 %

Under $25,000

17.1%

25.0 %

χ2(76, N = 83) = 83.00

.41

$25,000-$60,000

19.5 %

13.9 %

$60,000-$100,000

26.8 %

30.6 %

$100,000-$150,000

22.0 %

22.2 %

Prefer not to answer

14.6 %

8.3 %

Employed full-time (>40 hrs/wk)

14.6 %

13.9 %

χ2(57, N = 83) = 52.00

.24

Employed part-time (<40 hrs/wk)

48.8 %

41.7 %

Unemployed

29.3 %

33.3 %

Self-employed

7.3 %

11.1 %

10 or younger

0.0 %

0.0 %

χ2(36, N = 83) = 34.89

.17

10-15

14.3 %

3.5 %

16-18

42.9 %

41.4 %

19 or older

42.9 %

55.1 %

Yes

13.9 %

20.0 %

χ2(19, N = 83) = 25.12

.40

No

86.1 %

80.0 %

None

8.3 %

3.3 %

χ2(76, N = 83) = 91.38

.84

One

19.4 %

40.0 %

Two

24.0 %

16.7 %

Three

22.2 %

16.7 %

All four

25.0 %

23.3 %

Yes

86.1 %

69.0 %

χ2(38, N = 83) = 53.59

.07

No

13.9 %

24.1 %

Gender

Vaping Behaviour (Past 30 Days)

Ethnicity

Household Income

Employment Status

Age First Tried Vaping

Parental Vaping Presence

Four Closest Friends that Vape

Other Products/ Devices Used

53

Prefer not to say

0.0 %

6.9 %

Note. Standard deviation presented in parentheses; PMT protection motivation theory group, Control general health information group,
Academic year within institution

4.2

Group Differences
4.2.1 Threat Appraisal Beliefs Towards Vaping
Separate one-way factorial repeated measure ANOVAs showed that the two
treatment groups differed significantly across time on PS and PV (See Table 2, Figure 4,
and Table 3). Specifically, participants in the PMT intervention group increased their PV
scores from baseline (T0) to 7-day post-treatment (T1) to a greater extent than their
attention control counterparts (See Figure 4). PV then decreased from 7-day posttreatment (T1) to 30-day post-treatment (T2) and increased from 30-day post-treatment
(T2) and 45-day post-treatment in a similar manner for both groups. For perceived
severity (PS), participants in the PMT intervention group increased PS scores from T0 to
T1, whereas PS scores remained relatively stable (slight decrease) from T0 to T1 for
those in the attention control condition. PS then decreased from T1 to T2 and remained
stable from T2 and T3 for those in the PMT intervention. In contrast, PS remained
relatively stable (slight decrease) from T1 to T2, and T2 to T3 for those in the attention
control condition (See Figure 4).

4.2.2 Vaping Intention
Non-significant treatment by time group differences for intention to reduce vaping
behaviour were found (See Table 2, Figure 4, and Table 3). However, it is important to
note that the effect size for this interaction was moderate in size and favoured the PMT
intervention group. Specifically, participants in the PMT intervention group increased
their intention scores from baseline (T0) to Day 7 (T1) to a greater extent than their
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control counterparts (See Figure 4). This pattern of divergence remained consistent in the
PMT group from T1 to Day 30 (T2) then evolved into a gradual increase in intention
from T2 to Day 45 (T3). In contrast, the attention control group decreased from baseline
to T1 and remained uniform from T1 to T3 (See Figure 4).

4.2.3 Vaping Behaviour
Non-significant effects were revealed between treatment groups for vaping
behaviour for the follow-up assessments (See Table 2, Figure 4, and Table 3). The effect
size for this interaction was large, and generally favoured the PMT intervention group.
Specifically, participants in the PMT intervention and attention control group both
reported their greatest change in vaping behaviour from baseline to T1 (See Figure 4).
Although both groups saw a decline, PMT intervention group reported a greater change.
From T1 to T2, behaviour saw a slight increase (consistent between both treatment
groups), followed by a small decline for the PMT intervention group and a steep decline
for the experimental group from T2 to T3.
Table 2 Treatment by time interaction effects for threat appraisal, intention, and behaviour between treatment conditions
Variables

F (1, 28)

p

Partial Eta

Observed

Squared (ηp2)

Power

Perceived Vulnerability

3.28

.036

.27

.69

Perceived Severity

3.69

.025

.31

.74

Intention

124.7

.284

.09

.26

Behaviour

8.08

.123

.22

.47
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Table 3 Mean and standard deviation for threat appraisal, intention, and behaviour for PMT and Control condition
Variables

T0 (M(SD))

T1

T2

T3

Perceived Vulnerability

3.95 (2.4)

6.02 (2.4)

4.98 (2.8)

5.22 (2.7)

Perceived Severity

5.59 (2.8)

8.16 (1.5)

6.62 (2.3)

6.68 (2.7)

Intention

4.53 (2.5)

5.30 (2.8)

5.30 (2.8)

5.40 (3.0)

Behaviour

3.36 (1.3)

2.0 (1.2)

2.36 (1.1)

1.91 (0.8)

Variables

T0 (M(SD))

T1

T2

T3

Perceived Vulnerability

4.77 (1.5)

5.19 (2.4)

4.31 (2.3)

4.72 (2.2)

Perceived Severity

5.73 (1.9)

5.72 (2.1)

5.37 (2.2)

5.22 (2.4)

Intention

4.25 (2.2)

3.78 (2.5)

3.78 (2.5)

3.78 (1.9)

Behaviour

2.75 (1.0)

2.13 (1.0)

2.50 (1.2)

2.44 (.73)

n = 15

n = 16

Note. T0 = Baseline, T1 = Day 7, T2 = Day 30, T3 = Day 45
Figure 4 Mean and standard error scores between treatment groups across time for PV, PS, intention, and behaviour

Note. T0 = Baseline, T1 = Day 7, T2 = Day 30, T3 = Day 45
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4.3

Correlation Analysis
Bivariate Pearson correlations between threat appraisal variables, vaping

intention, and vaping behaviour at baseline and follow-up are presented in Table 4. In line with
the tenets of PMT, if bivariate relations were found between the predictor variables and the
criterion variable of interest, they were then entered into a regression analysis to determine their
uncorrelated contribution. Perceived vulnerability and severity were significantly related to each
other and intention at multiple follow-up time points. Goal intention was not found to be
significantly related to behavior at any time point.

4.4

Linear Regression Analysis
Linear Regression analysis between bivariate variables (PV, PS, Intention) are presented

in Table 5. The linear regression for predicting intention found both PV and PS to be significant
influencers. Moreover, PV is revealed to be the strongest measure of vaping intention with
significant effects at T0, T1 and T2, followed by a significant PS effect at T3.
Table 4 Bivariate correlations between the modified PMT variables with intention and behaviour
Variable
Baseline (T0)
1. Perceived Vulnerability
2. Perceived Severity
3. Intention
4. Behaviour

n

Mean

SD

1

2

3

4

63
62
64
65

5.29
6.30
5.02
2.97

2.48
2.36
2.52
1.36

-

.71**
-

.66**
.49**
-

.28*
.14
.13
-

Day 7 (T1)
1. Perceived Vulnerability
2. Perceived Severity
3. Intention
4. Behaviour

51
50
40
50

5.89
7.16
4.70
2.32

2.42
1.97
2.76
1.24

-

.56**
-

.59**
.31
-

-.03
-.09
.18
-

Day 30 (T2)
1. Perceived Vulnerability
2. Perceived Severity
3. Intention
4. Behaviour

39
39
38
38

4.76
6.13
4.67
2.53

2.38
2.15
2.78
1.20

-

.72**
-

.78**
.51**
-

.19
.18
.26
-

Day 45 (T3)
1. Perceived Vulnerability
2. Perceived Severity
3. Intention
4. Behaviour

31
31
31
31

4.96
5.91
4.56
2.16

2.44
2.58
2.59
0.82

-

.45*
-

.38*
.53*
-

.12
.16
.23
-

Note. * p < .05; ** p < .01
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Table 5 Linear regression analyses predicting intention
Baseline (T0)

Day 7 (T1)

Day 30 (T2)

Day 45 (T3)

Variable

B (SE B)

β

B (SE B)

β

B (SE B)

β

B (SE B)

β

Perceived Vulnerability

.31 (.28)

.27

.67 (.18)***

.56

1.0 (.18)***

.86

.17 (.19)

.16

Perceived Severity

.21 (.26)

.22

-.04 (.22)

-.03

-.12 (.22)

-.09

.41 (.19)*

.41

Note. Only PMT variables which were significantly correlated with intention were entered in each regression model.
* p < .05; ** p < .01; *** p < .001

4.5

Missing and Excluded Data
Multiple imputation analyses were implemented for all missing data points across all

variables within both treatment groups. This strategy of analyses was used to negate the potential
statistical uncertainty associated with the presence of missing data by creating several different
plausible imputed data sets and appropriately combining result obtained from each of them.
Through data analysis patterns of missing values our missing data was shown as ‘missing at
random’, with 42.24 % of all values collected containing missing data, negating the decision to
use ‘single imputation’ or ‘complete case analysis’ strategies (Jakobsen et al., 2017).

4.6

Imputed Results
Separate data analyses for missing values (T0, T1, T2, T3) were replaced using a multiple

imputation analyses methodology across all variables within both treatment groups. This strategy
of analyses was used to negate the potential statistical uncertainty associated with the presence of
missing data by creating several different plausible imputed data sets and appropriately
combining results obtained from each of them.

4.7

Imputed Group Equivalency
One-way ANOVAs revealed no significant differences indicating systematic differences

between groups with respect to age, F(1, 422) = 3.67, p = .06; in addition, the mean academic
year of the two groups proved to be insignificant (p > .05) (3.19 (SD = 1.34) PMT; 3.08 (SD =
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1.56) control). Moreover, Chi-square tests indicated no significant differences between gender
(χ2 (1, N = 448) = .05, p = .83), vaping behaviour (χ2(4, N = 448) = 15.55, p = .17), household
income (χ2 (4, N = 448) = 9.06, p = .13), employment status (χ2 (3, N = 448) = 6.3, p = .10), or
prevalence among friends (χ2(4, N = 393) = 27.00 = p = .39 within treatment conditions.
However, as can be seen from Table 1, regarding demographic variables, significant differences
emerged with ethnicity, age first tried, parental vaping presence, and other products/devices
used. Therefore, a repeated measures ANCOVA was conducted to determine a significant
interaction effect to reject the null hypothesis and meet the homogeneity of regression between
treatment groups and vaping intention, controlling for ethnicity, age first tried, parental vaping
presence, and other products/devices used. Results showed a non-significant effect of treatment
group on vaping intention after controlling for aforementioned covariates except for age first
tried, F(1, 346) = 11.85, p < .05. Post-hoc of age first tried between groups revealed a nonstatistically significant (p = .95) effect between PMT intervention and attention control, failing to
reject the null hypothesis that we meet homogeneity of regression but the covariate not having a
significant effect on intention to vape.
Table 6 Imputed demographic characteristic for the two treatment conditions
Variable

PMT (n = 82)

Control (n = 57)

Statistic (n = 139)

p level

Age in years (SD)

21.91 (3.51)

22.54 (3.51)

F(1, 442) = 3.67

.06

Academic Year

3.19 (1.34)

3.08 (1.56)

F(1, 442) = .70

.40

Male

46.1 %

45.5 %

χ2(1, N = 448) = .05

.83

Female

53.9 %

54.5 %

Other

0.0 %

0.0 %

Prefer not to answer

0.0 %

0.0 %

1-5 days

17.59 %

31.01 %

χ2(4, N = 448) = 15.55

.17

5-15 days

35.71 %

32.55 %

16-29 days

18.68 %

20.94 %

All 30 days

28.02 %

15.50 %

Gender

Vaping Behaviour (Past 30 Days)

Ethnicity
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Caucasian

60.1 %

50.0 %

African American

4.4 %

2.6 %

Hispanic American

2.6 %

5.8 %

Asian American

15.3 %

19.9 %

Indigenous Peoples

11.0 %

6.4 %

Other

6.6 %

15.3 %

Under $25,000

17.1%

25.7 %

$25,000-$60,000

17.5 %

16.0 %

$60,000-$100,000

30.7 %

26.9 %

$100,000-$150,000

20.6 %

23.7 %

Prefer not to answer

14.1 %

7.7 %

Employed full-time (>40 hrs/wk)

16.2 %

10.9 %

Employed part-time (<40 hrs/wk)

46.5 %

42.3 %

Unemployed

27.2 %

37.2 %

Self-employed

10.1 %

9.6 %

10 or younger

0.0 %

0.0 %

10-15

13.6 %

3.7 %

16-18

43.2 %

40.7 %

19 or older

43.2 %

55.6 %

Yes

13.2 %

21.0 %

No

86.8 %

79.0 %

None

8.9 %

2.2 %

One

20.5 %

39.1 %

Two

25.8 %

15.2 %

Three

21.1 %

18.1 %

All four

23.7 %

25.4 %

Yes

84.4 %

70.1 %

No

15.6 %

22.6 %

Prefer not to say

0.0 %

7.3 %

χ2(5, N = 448) = 17.75

.01

χ2(4, N = 448) = 9.06

.05

χ2(3, N = 448) = 6.3

.09

χ2(2, N = 382) = 13.21

.01

χ2(1, N = 393) = 4.72

.03

χ2(4, N = 393) = 27.00

.62

χ2(2, N = 388) = 21.01

.01

Household Income

Employment Status

Age First Tried Vaping

Parental Vaping Presence

Four Closest Friends that Vape

Other Products/ Devices Used

Note. Standard deviation presented in parentheses; PMT protection motivation theory group, Control general health information
group, Academic year within institution

4.8

Imputed Group Differences
4.8.1 Threat Appraisal Beliefs Towards Vaping
Separate one-way ANOVAs showed that both treatment groups differed
significantly on PS and PV across time (See Table 7, Figure 5, and Table 8). Specifically,
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participants in the PMT intervention group increased their PV scores from baseline (T0)
to Day 7 (T1) to a greater extent than their attention control counterparts (See Figure 5).
PV then decreased from T1 to Day 30 (T2) and again from T2 to Day 45 (T3) in a similar
manner for both groups. For perceived severity (PS), participants in the PMT intervention
group increased PS scores from T0 to T1, whereas PS scores remained relatively stable
(slight decrease) from T0 to T1 for those in the attention control condition. PS then
decreased from T1 to T2 and spiked up again from T2 to T3 in the PMT intervention. In
contrast, PS remained relatively stable (slight decrease) from T1 to T2 but saw a jump
from T2 to T3 in the attention control condition (See Figure 4).

4.8.2 Vaping Intention
Significant treatment group differences across time for intention to reduce vaping
behaviour were revealed (See Table 7, Figure 5, and Table 8). Specifically, participants
in the PMT intervention group increased their intention scores from baseline (T0) to Day
7 (T1) to a greater extent than their control counterparts (see Figure 5). This pattern of
divergence remained consistent from T1 to Day 30 (T2) then revealed an increase in
intention from T2 to Day 45 (T3), In contrast, the attention control group decreased from
baseline to T1, remained unform from T1 to T2 and revealed another gradual decrease
from T2 to T3 (See Figure 5).

4.8.3 Vaping Behaviour
Significant treatment group differences across time for vaping behaviour were
found (See Table 7, figure 5, Table 8). Specifically, participants in the PMT intervention
and attention control group reported a gradual decline (PMT intervention holding the
greater change) from baseline to T1 (See Figure 4). From T1 to T2, behaviour saw a
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slight increase (consistent between both treatment groups), followed by the largest
change from T2 to T3 (PMT intervention holding the greater difference) showing a
decline in vaping behaviour at final follow-up (See Figure 5).
Table 7 Imputed treatment by time interaction effects for threat appraisal, intention, and behaviour between treatment conditions
Variables

F (3, 413)

p

Partial Eta

Observed

Squared (ηp2)

Power

Perceived Vulnerability

8.52

.001

.06

.99

Perceived Severity

10.08

.001

.07

1.0

Intention

815.6

.001

.05

.99

Behaviour

68.04

.001

.06

.99

Table 8 Imputed mean and standard deviation for threat appraisal, intention, and behaviour for PMT and Control conditions
Variables

T0 (M(SD))

T1

T2

T3

Perceived Vulnerability

4.71 (2.8)

6.42 (3.9)

5.86 (4.0)

4.09 (21.7)

Perceived Severity

6.34 (2.8)

8.15 (3.0)

7.14 (3.2)

11.96 (19.9)

Intention

4.66 (2.9)

5.08 (2.5)

5.08 (2.5)

5.89 (9.1)

Behaviour

3.06 (1.4)

2.69 (1.4)

2.93 (1.4)

1.84 (0.8)

Variables

T0 (M(SD))

T1

T2

T3

Perceived Vulnerability

5.71 (2.4)

5.54 (4.1)

5.06 (3.8)

4.23 (17.0)

Perceived Severity

6.37 (2.3)

6.08 (3.1)

6.08 (3.6)

7.67 (16.1)

Intention

5.03 (3.2)

4.13 (2.4)

4.13 (2.4)

3.59 (5.9)

Behaviour

2.84 (1.2)

2.64 (1.3)

2.95 (1.4)

2.27 (0.8)

n = 244

n = 172

Note. T0 = Baseline, T1 = Day 7, T2 = Day 30, T3 = Day 45
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Figure 5 Imputed mean and standard error scores between treatment groups across time for PV, PS, intention, and behaviour

Note. T0 = Baseline, T1 = Day 7, T2 = Day 30, T3 = Day 45

4.9

Imputed Correlation Analysis
Bivariate Pearson correlations between threat appraisal variables, vaping intention, and

vaping behaviour at baseline and follow-up are presented in Table 9. If bivariate relations were
found between the predictor variables and the criterion variable of interest, they were then
entered into a regression analysis to determine their uncorrelation contribution. Perceived
vulnerability and severity were significantly related to each other and intention at multiple
follow-up time points, however, only PS showed significant effect on intention and behaviour at
final follow-up (T3). In addition, intention did not maintain a consistently significant association
with vaping behaviour. Specifically, no association was found at baseline, T1, and T3. However,
a positive association was found at T2, suggesting that higher intentions to reduce vaping are

63

associated with higher rates of vaping behaviour. Due to this contradictory finding this
relationship was not pursued further through regression analysis.

4.10 Imputed Linear Regression Analysis
Linear Regression analysis between significant bivariate variables (PV, PS, and
Intention) are presented in Table 10. For complete data the linear regression for predicting
intention found both PV and PS to be significant influencers. Moreover, the imputed analysis
supports the completed data in that PV is revealed to be the strongest measure of vaping
intention with significant effects at all timepoints, with PS strengthening in effect over time,
holding a significant effect at T2 and T3 timepoints (See Table 10).
Table 9 Imputed bivariate correlations between the modified PMT variables with intention and behaviour
Variable
Baseline (T0)
1.Perceived Vulnerability
2. Perceived Severity
3. Intention
4. Behaviour

n

Mean

SD

1

2

3

4

448
447
449
450

5.12
6.36
4.81
2.97

2.65
2.61
3.05
1.35

-

.61**
-

.61**
.38**
-

.25**
.10*
.08
-

Day 7 (T1)
1.Perceived Vulnerability
2. Perceived Severity
3. Intention
4. Behaviour

436
435
425
435

6.07
7.31
4.70
2.70

4.06
3.23
2.49
1.33

-

.43**
-

.34**
.20**
-

.03
-.00
.09
-

Day 30 (T2)
1.Perceived Vulnerability
2. Perceived Severity
3. Intention
4. Behaviour

424
424
423
423

5.54
6.71
4.70
2.93

4.01
3.33
2.49
1.39

-

.80**
-

.43**
.29**
-

.19**
.19**
.17**
-

Day 45 (T3)
1.Perceived Vulnerability
2. Perceived Severity
3. Intention
4. Behaviour

416
416
416
416

4.13
10.23
4.94
2.02

20.28
18.68
8.05
0.81

-

-.20**
-

.59**
.13**
-

.02
-.18**
-.05
-

Note: * p < .05; ** p < .01
Table 10 Imputed linear regression analyses predicting intention
Baseline (T0)

Day 7 (T1)

Day 30 (T2)

Day 45 (T3)

Variable

B (SE B)

β

B (SE B)

β

B (SE B)

β

B (SE B)

β

Perceived Vulnerability

.72 (.06)***

.63

.20 (.03)***

.31

.33 (.05)***

.52

.30 (.02)***

.65

Perceived Severity

.00 (.06)

.00

.06 (.04)

.07

-.11 (.06)*

-.15

.12 (.02)***

.26

Note. Only PMT variables which were significantly correlated with intention were entered in each regression model.
* p < .05; ** p < .01; *** p < .001
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Chapter 5
5

Discussion
The results of the present study support the view that both threat appraisal applications

grounded in PMT (PV, PS) are effective mechanisms to influence reduced vaping intention,
however PV maintains the strongest effect on intention within a 6-week protocol design.
Findings for both complete and imputed data highlight the isolated corroboration of threat
appraisal in predicting intentions in a Canadian university student population. Among these two
sets of data analysis, general findings regarding threat appraisal and intention are replicated.
Beyond these general observations, commentary related to the specific hypothesis' that were
generated warrant further examination.

5.1

Hypothesis I
It was hypothesized that those exposed to the threat appraisal information grounded in the

PMT components of severity and vulnerability would score higher on purpose-built questions
reflecting these components than their attentional control counterparts. Analysis within
completed data revealed significant differences between PV and PS with respect to the
experimental group (PV, p = .04; PS, p = .03) over the 6-week study period. Imputed data results
supported these findings with greater significance among threat variables (PV, p = .001; PS p =
.001). Partial eta squared was used to measure effect size for our repeated measures design, using
the following values to interpret the strength of the effect: ηp2 = .01 indicates a small effect; ηp2 =
.05 indicates a medium effect; ηp2 = .09 indicates a large effect (Lakens, 2013). Among
completed and imputed data sets, our effect size using this criterion indicated that PS was most
strongly influenced, follow by PV across the 6-week protocol. The emergence of PS being the
more susceptible to our threat intervention may be explained by the potential health effects of

65

vaping described by health professionals in the experimental group. As a relatively new product
in North America, the potential health effects of vaping remain unclear. To those participating in
this study, hearing that vaping may cause sudden pneumonia or a pneumothorax (collapsed
lung), could be a reason for the shown raise in participant perception of the severity of harm
related to vaping. With respect to PV, we chose to include the dialogue of vaping health threat
focused on young adult populations. Therefore, the perceived potential severity of health
outcomes mentioned above were directly linked to the vulnerability of the participants age group.
This experimental design would explain why a significant difference for both PS and PV was
consistently shown for both data sets. In addition, because vaping is a relatively new device, the
greater difference shown in PS may be a result of the participant’s learning of the severity of
these health outcomes for the first time, causing PS to show a greater difference in change
compared to the components of perceived vulnerability. This finding may also be explained by
the presence of defensive denial among the young adult population of students in university with
evidence to suggest that younger people perceive less vulnerability to health risks (Millstein &
Halpern-Felsher, 2002). This may have attenuated the impact of the vulnerability manipulation.
According to the relationship of means within the completed data, both variables related to threat
appraisal (PV, PS) elucidated the largest difference in variability from baseline to T1 (following
intervention). This finding shows that the effect of the threat appraisal intervention on PV and PS
is strongest immediately after receiving health risk information. However, among the imputed
data, the largest difference was apparent between Day 30 (T2) and Day 45 (T3), garnering future
research to further investigate the difference in perceived PV and PS components of threat
appraisal over longer follow-up periods.
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While studies have used the constructs of PMT in the past, we are the first study to isolate
the threat appraisal components of vaping within an educational video-implementation design.
Given the short existence of modern vaping devices, there is no research to support the health
benefits of reducing or abstaining from vaping behaviour (response efficacy). Therefore, to
maintain confidence in our intervention implementation design, we formatted our study to only
include the literature supported health risk information of continued vaping and did not propose
false speculations related to the health benefits of reducing and abstaining from vaping.

5.2

Hypothesis II
It was hypothesized that those exposed to the threat appraisal information will show

lower intentions to vape and lower vaping use compared to their attentional information
(nutrition and lifestyle information group) control counterpart. With respect to intention, analysis
within completed data revealed non-significant reductions in intentions to vape over time.
Following threat information implementation at Day 7 (T1), both sets of data showed an increase
in intention to vape less with consistent intentions at Day 30 (T2) followed by a period between
T1 and T2 where the intention to reduce vaping within the PMT intervention group remained
uniform between both data sets. Following this stage of consistent intention measures, both data
sets showed an increase in intention from T2 to Day 45 (T3). Regarding the imputed data, this
change from T2 to T3 was the largest difference across timepoints for intention. These findings
warrant future research to further investigate the difference in PV and PS components of threat
appraisal on intention over longer follow-up periods. With respect to the PMT intervention
group, the increase from T0 to T1 is explained by the application of the threat intervention while
the increase from T2 to T3, consistent across both data sets of participants in the PMT
intervention, may be a factor of increased perceived severity and vulnerability.
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Although we see a positive change in intention over time for the PMT intervention group,
the lack of statistically significant change shown in the completed data analysis can be explained
by low observed power (β = .26) resulting from the small sample size in the PMT intervention
group. After conducting the imputed data analysis, we saw a large increase in observed power (β
= .99) and only a modest change in effect size (completed data: ηp2 = .09; imputed data: ηp2 =
.05) between the two data sets, revealing intentions to reduce vaping in the imputed data set to
show statistically significant change over time. This change in statistical significance is best
explained by the larger sample of participants included in the PMT intervention group with the
imputed data revealing the greater observed power. This modest change in effect size and the
similarity of intention change over time for the PMT group between data sets reinforces our
confidence in the imputed data analysis. Overall, we found consistent evidence to support the
hypothesis that the threat appraisal intervention will have a significant positive effect on
intentions to vape less. This is in line with past PMT literature focusing on similar behaviours
(such as conventional cigarette smoking), research that found threat components are effective
constructs to influence intention (Thrul et al., 2013).
With respect to vaping use, we found inconsistent and thus less convincing evidence for
the effectiveness of the PMT intervention. The complete data analysis showed a large nonsignificant treatment effect over time for behaviour for the PMT intervention group (ηp2 = .22; p
= .12). The observed power for this analysis was low β = .47; In contrast, the imputed data
analysis, reached statistically significant (p = .001), with a large increase in observed power (β =
.99), but large reduction in effect size (ηp2 = .06). This large discrepancy in effect size for
behaviour between data sets raises the question “What is the real treatment effect for vaping
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use?” The benefits of collecting follow-up vaping behavior data must be weighed against the
costs of having too much missing follow-up data to estimate.

5.3

Hypothesis III
It was hypothesized that increases in both severity and vulnerability of vaping usage will

be associated with a reduction in intentions to vape. Furthermore, that reduction in intentions to
vape will be associated with lower vaping use. Bivariate analysis findings revealed an iterative
association of significance between PV and PS with intention. Both PV and PS revealed a
significant influence in association with the threat appraisal intervention and influenced vaping
intention (See Table 4 and Table 9).
Among both data sets, bivariate correlation analysis revealed that PV corroborated
strongest with vaping intention overall. Completed data analysis revealed PV to be the strongest
indicator of intention at three time points (T0, T1, T2), while PS was shown to be the strongest
predictor at final follow-up (T3). Imputed data showed that PV and PS maintained a significant
effect for intention at all time points with PV holding the strongest effect at each timepoint.
Taken together, these correlation findings imply that the vaping intention reduction effects
observed favoring the experimental PMT group likely occurred because the PMT intervention
was able to successfully manipulate the threat appraisal constructs PV and PS.
Limited and inconsistent evidence was found to support relations between vaping
intentions and vaping use (behavior). For instance, a relationship between these two constructs
was only found with imputed data at T2. However, this association revealed a contradictory
relationship (β = .17) suggesting that increases in intentions to reduce vaping is associated with
increases in vaping behavior. In turn, because of the moderate-to-large effect in vaping use
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favoring the experimental group in both complete and imputed data sets (hypothesis II), it is
concluded that intention was not responsible for behaviour treatment group differences observed.
Past PMT literature focusing on behaviour change supports our findings that both PS and
PV are effective constructs to influence intention. However, PMT studies focusing on the
corroboration between smoking intention and behaviour in well-known products, such as
conventional cigarettes, show a stronger relationship between the two variables. The absence of
association between intention and behaviour may be explained by the missing components
related to planned behaviour (Teasdale et al., 2016). The outcomes within our study, along with
previous literature (Zhao et al., 2020), leads us to believe that with the emergence of evidence
supporting vaping cessation for reduced health risk, the implementation of a planned behaviour
framework in future research would bridge the gap between goal intention and behavior (Wu et
al., 2014).

5.4

Future Direction
The inclusion of future studies using other threat information models such as the looming

vulnerability principle (Riskind, 1997) that explains how people become anxious when they
perceive threats as growing larger and accelerating towards them over time, are warranted to
expand on health threatening behaviour change research. In addition, the future scope of vaping
research should explore how vaping behaviour might augment the risk of developing health
problems or if the general notion of vaping as a healthier alternative to smoking cigarettes is true.
Moreover, the scale correspondence for the questions measuring intention and behaviour would
be improved with the implementation of similar language from the intention questions to the
self-reported behaviour measure to elicit a more cohesive transition. Additionally, the inclusion
and manipulation of implementation constructs to serve as bridging (mediating) the intention-

70

behaviour gap is warranted. Although attempts were made to standardize intervention delivery
(i.e., using pre-determined email scripts), the possibility of sampling bias can’t be ruled out.
Importantly, future research is needed to verify the findings of this study and further investigate
the relationship between perceived vulnerability and perceived severity to reduce vaping
intention and behaviour to design effective health behaviour change interventions for student
populations.
Regarding the effect of PS later in follow-up (T3), further investigation in future PMT
threat appraisal research is warranted. Related to future inquiry, although we influenced PS
greater than PV through our threat information intervention, PV was shown to be the greater
predictor of intention. This observed threat appraisal corroboration to intention should be
examined in future studies and a better way to effect PV needs to be designed in future
experimental interventions to have a stronger influence on intention.

5.5

Strengths & Limitations

5.5.1

Strengths

There are a number of strengths in the present study including the PMT threat appraisal
design was derived from theory-driven interventions regarding past PMT literature for
behaviour intention. In addition, vaping intervention information was provided by
professional authorized health researchers, addressing the direct health effects of vaping
prospectively, extending the existing cross-sectional research using scientifically supported
information rather than bogus figures to embellish greater perceived threat related to vaping.
Another strength of our threat intervention is the cost-effectiveness and scalability of delivery
to reach population numbers. This design can therefore be easily implemented in settings of
public and private health offices with limited financial or structural obstacles to help effect
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change in larger populations. Regarding the measurement tools of our threat intervention, the
consistency in data collection using research-supported questionnaires (McNair et al., 1971;
Spielberger et al., 1983; Gaston & Prapavessis, 2009; Courneya & Hellsten, 2001; Schwarzer
et al., 2011; Schacham, 1983; Milne et al., 2000) supports the reliability of accurate
representations of behaviour intention and action-behaviour of the Canadian university
student population who vape. Moreover, the data collected from the Canadian student
population spans from 23 different universities across six provinces, accounting for an
accurate representation of the desired sample population in Canada. Lastly, the precise and
consistent measure of the Canadian university student population who vaped more than 3
times in the past 30 days, provides an accurate representation of the potential changes in
intention related to university students receiving specific health risk information.

5.5.2

Limitations

Despite the aforementioned strengths, this study is not without limitations. The scales
used to measure vaping behaviour were collected using a self-report method. To combat this
issue, future studies should objectively measure vaping behaviour using air quality monitors
that accurately detect various gases and fumes, such as those left behind by vaping devices to
ensure accurate recordings of behaviour. In addition, a portion of data was missing
participant ID numbers and were removed due to lack of representation or loss to follow-up.
Due to the prospective design, 30% of the sample that completed the baseline survey failed to
complete the second survey. Future studies can address this by implementing questionnaires
designed to restrict participants from submitting their responses before answering each
question. Moreover, participant ID numbers should be selected out of an attached list of
numbers rather than an open text box to aid in acuity of participant identification response. In
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addition, the PMT questionnaire, secondary, and tertiary scales were modified to examine the
measurement of intention and behaviour related to vaping where they have previously only
been used for other health-threatening behaviour (i.e., conventional cigarette usage). In
response, these questionnaires need to go through further psychometric evaluation in future
design studies to strengthen their accuracy of effect. Importantly, the 6-week length of study
does not predict continued habitual behaviour. As a result, future studies should examine the
effect of threat appraisal application within a longitudinal study design. Additionally, the
results can only be generalized to a Canadian university population and more work needs to
be done to determine the applicability to other populations such as children, adults, and older
adults in Canada, as well as internationally. It is likely that different age groups, such as
adults, may have a stronger threat perception towards vaping compared to adolescent, youth,
older adult, and university student populations (Wright et al., 2006). Moreover, as the
research surrounding the health benefits of abstaining from vaping behaviour remains
unclear; the assumption that reducing and/or abstaining from vaping all together to benefit
your overall health remains uncertain. As previously acknowledged above, we need to further
examine the effect of dynamic and static threat, as well as the influence of goal intention and
behaviour planning principles to explore the optimal conditions under which this effect
occurs (i.e., does an evolving threat influence intention; how important are planning
principles for intentions to reduce behaviour to be successful?). While the present research
addressed the effect of static threat and provided evidence for the benefit of threat
information to influence intention, future research designs continuing to explore the optimal
conditions of intention and behaviour change are warranted.
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Chapter 6
6

Conclusion
In conclusion, this is the first study to support the view that presenting isolated factual

threat appraisal information to Canadian university students, concerning the possible negative
health effects of vaping, may be an effective resource for vaping intention and behaviour change
research. However, more studies are needed to further investigate the relationships between
threat appraisal and reduction in vaping intention and behaviours to design effective health
behaviour change interventions for student populations and confirm whether such an intervention
can lead to long-lasting behaviour change. This discovery, in addition to the inclusion of PMT
coping appraisal in future vaping research, may help shed more light on the intention-behaviour
gap observed in vaping and support behaviour change after the intention has been set.
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Script for General Announcement
Study Title: Information Interventions to Reduce Vaping in a Student Population
Principal Investigator:
Dr. Harry Prapavessis, PhD
Department of Kinesiology
Western University
hprapave@uwo.ca

Student-Investigator:
Babac Salmani, MA
Department of Kinesiology
Western University
bsalmani@uwo.ca

Date: [Insert Date]
Dear Student:
Hello, my name is Babac Salmani and I am the Student Investigator (SI) in the 6-week study on
vaping behaviour among university students in Canada. As part of the research investigation,
participants are responsible for reviewing and submitting a signed Letter of Information/Consent
form to the SI.
You are invited to participate in a research study to evaluate intention to vape and subsequent
vaping behaviour. I have attached a Letter of Information/Consent form to this email to outline
the background, purpose, and description of the study along with the responsibilities that you
must uphold as a participant.
As a valued participant in our study, we are excited to gather your feedback to help expand the
understanding around vaping behaviour. Please take a few minutes and review the Letter of
Information/Consent attached to this email and submit a signed copy to the SI email shown here:
bsalmani@uwo.ca.
7 additional days are provided to participants to review and submit their acknowledgment of the
study considerations and interventions from the day they are sent out; in order to become a
participant, the Letter of Information/Consent form must be complete and submitted within this
time.
Participation is voluntary and there are no consequences for choosing not to participate or
withdrawing from the study. Confidentiality of all participants will be maintained. The data will
be kept secure, and password protected.
Any additional questions regarding the project can be directed to me, Babac Salmani at
bsalmani@uwo.ca.
Respectfully,
Babac Salmani
Student Investigator
Western University
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Mass Email Recruitment Script
Subject Line: Vaping Behaviour Study (Mass Email Recruitment)
Dear Student,
You are invited to participate in a research study to evaluate intention to vape and subsequent vaping
behaviour. This study was designed to develop a greater understanding of how to effect behaviour-intention
and action-behaviour change regarding vaping in university students across Canada.
We are looking for student volunteers to complete 12 online surveys at four timepoints over a 6-week period
during the academic year: one survey at day 1 (Baseline), one on day 7 (T1), and one on day 30 (T2), and one
on day 45 (T3). (Start date (Baseline) will depend on when you review and submit your consent form to the
student-investigator (SI)). The surveys should take you about 10 minutes total to complete.
The following inclusion criteria is required in order to participate in this study analysis:
1.
2.
3.
4.
5.
6.
7.
8.
9.

Provision of signed and dated informed consent form
Ability to read and understand English
Stated willingness to comply with availability for the duration of the study
Males and females; Age 18 years and older
Self-report as current users of vaping products (>3x in the past 30 days)
Willingness to adhere to the study intervention regimen
Enrolled full-time within a registered Canadian university during the 2020-2021 school year
Access to necessary resources for participating in a technology-based intervention (i.e., computer, smartphone,
internet access)
Willingness to stop (or at least decrease the frequency of) vaping

The following exclusion criteria will effectively terminate your inclusion in this study and prevent your data
from contribution to study analysis:
1. Currently practicing in behaviour therapy treatment specific to vaping or attending a rehab centre
2. At the time of signing/submitting this consent form you are under the legal age of 18
3. Failure to complete and submit completed questionnaires within the 7-day study timeframe, starting
the day that set of surveys is emailed to you by the student investigator
Participants will be notified immediately by the SI, via emails provided by individual participants, of their
ineligibility or exclusion from the study and the immediate termination of their study data.
As a thank you for participating, you will have the opportunity to submit your e-mail into a draw after
submitting all three surveys for a chance to win one of three gift cards to Subway Restaurants.
If you are interested in participating, please contact the student-investigator at bsalmani@uwo.ca for further
instruction.
Sincerely,
Dr. Harry Prapavessis, PhD
Principal Investigator
Western University

Babac Salmani, MA
Student-Investigator
Western University
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Letter of Information
Letter of Information
You are invited to participate in a study that aims to determine whether information about risks
associated with vaping can serve as a source of intention for behaviour change in adult youth.
Your participation in this study will be required for six weeks and you will have to watch a 10minute online video and complete a purpose-questionnaire. As a participant, you will be asked to
complete three self-report questionnaires over the six-week study period. The questionnaires will
assess your past and current vaping behaviour, a questionnaire about your perceptions of vaping
behaviour, a questionnaire about your intentions to try and reduce vaping behaviour as well as a
questionnaire assessing some mood variables. This will take approximately 15-20 minutes of
your time and each questionnaire will be filled out at three time points: upon entry into the study,
one week later, and at the end of the study (approximately 4 weeks later).
All information will be kept strictly confidential and your name will not be included or
associated with the data. You will not be identified individually in any way and all digital data
will be contained under a password-protected, locked external drive on the campus of Western
University.
You may decline to answer any questions or withdraw at any time. However, once your
questionnaire has been submitted you cannot withdraw because there is no way to know which
questionnaire was done by you.
This study has been reviewed and received ethics clearing through the Research Ethics Board at
Western University. If you have any comments or concerns about your rights as a research
participant, please contact the Research Ethics Office at (519) 661-3036. Thank you for your
assistance in this project. Please keep a copy of this form for your records.
If you would like a summary of the results, or would like to contact the researchers for any other
reason, they can be reached at: bsalmani@uwo.ca or hprapave@uwo.ca
Sincerely,
Babac Salmani (bsalmani@uwo.ca)
Dr. Harry Prapavessis (hprapave@uwo.ca)
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Letter of Information and Consent

Letter of Information and Consent
Study Title: Information Interventions to Reduce Vaping in a Student Population
Principal Investigator:
Dr. Harry Prapavessis, PhD
Department of Kinesiology
Western University
hprapave@uwo.ca

Co-Investigator:
Babac Salmani, MA
Department of Kinesiology
Western University
bsalmani@uwo.ca

INVITATION
You are invited to participate in a study because you have self-described yourself as someone who vapes. The purpose of this
study is to determine which types of sources of information are more effective in helping university students reduce their vaping
habits. You are being invited to participate in this research study because, as a student, you are part of a population in Canada
where the use of vaping products is relatively higher compared to the rest of the Canadian population.
BACKGROUND INFORMATION
According to Statistics Canada, more than one-third of Canadian students have tried vaping products at some point in their lives
with the highest rates of trying vaping being among young adults (18-24 years). These data points reinforce the trend that vaping
is becoming dangerously popular among Canadians, specifically among Canadian students. The purpose of this study is to find
out what effects an individual’s behaviour-intention and action-behaviour and how we can potentially reduce and manage the
uptake of vaping behaviour in Canadian students.
WHAT’S INVOLVED
Up to 150 students will participate in this study and it is expected that you will be in the study for six weeks. You will not have to
pay for any of the procedures/interventions with this study. If you decide to participate then you will be “randomized into one of
the groups described below.” Randomization means that you are put into a group by chance (like flipping a coin). Of the two
groups providing information, each will consist of different content. Participants in either group are required to complete all four
sets of surveys. There is no way to predict which group you will be assigned to. You will have 1 in 2 chances of being placed in
/any group. Neither you, nor the study staff can choose what group you will be in; group one will contain information regarding
the risks associated with vaping to your overall health. Group two will focus on tips associated with diet choices and lifestyle. At
the start of the six-week timeframe you will have to (all will be sent by the student investigator (SI) to the email you provide):
•
•
•

Complete a purpose-questionnaire and self-report questionnaires regarding vaping
Watch an 8-minute online video
Complete three self-report questionnaires over the remaining five-weeks of the study period

The purpose of the questionnaires is to understand how your intention and desire to vape changes over time. The questionnaires
will assess your past and current vaping behaviour, your perceptions of vaping, your intentions to try and reduce vaping
behaviour, as well as assess some potential changes in mood. The questionnaires will be filled out at four time points: upon entry
into the study (Day 1), one week later (Day 7), two weeks later (Day 30), and at the end of the study (Day 45). All questionnaires
will be sent to the email you provide to the SI, following the schedule above. Each set of questionnaires will take about 15
minutes to complete.
The following exclusion criteria will effectively terminate your inclusion in this study and prevent your data from contribution to
study analysis:
4.
5.
6.
7.

Activity restrictions that limit one’s ability to engage in questionnaire testing
Currently practicing in behaviour therapy treatment specific to vaping or attending a rehab centre
At the time of signing/submitting this consent form you are under the legal age of 18
Failure to complete and submit completed questionnaires within the 7-day study timeframe, starting the day that set of
surveys is emailed to you by the student investigator
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Participants will be notified immediately by the SI, via emails provided by individual participants, of their exclusion from the
study and the immediate termination of their study data.
POTENTIAL BENEFITS AND RISKS
An understanding of what information has the greatest influence on behaviour in students will help to design more effective
interventions to help reduce negative health behaviour in the future. In addition, you may learn more about the risks associated
with vaping or potential nutrition and lifestyle tips, depending on which group you are in, that may have a positive influence on
your health behaviour choices and overall health. A risk associated with participation in this study is the potential for preliminary
stress and anxiety as a result of reflecting on behaviour through surveys. Apart from the application of intervention, as personal
identifiers are being collected for this study, there is the risk of breach of privacy which may be a cause of added risk in
participation. To combat this risk, we have implemented the safe storage of all identifiable data on a password-protected,
encrypted Personal Vault via OneDrive to ensure participant privacy. As a participant, you may also experience no benefit from
participation in this study. If you notice a greater sense of mental distress or anxiety as a result of participation in the study
procedures, please contact Dr. Lisa Lee, a clinical psychologist as part of the study team, by email at info@drlisalee.com, or by
phone at (519) 878-4912. In addition, the Counselling Services of London, specialized in anxiety therapy and self-esteem
counselling, have offered their services as part of our study team at counselling@natashaminor.com or by phone at (226) 2701242, to any participants who feel distress. Both study team resources offer online services for study participants. Lastly, please
consider contacting the Centre for Addiction and Mental Health in Canada, at (519) 858-5144 if you feel the need for additional
aid.
SUMMARY OF TESTS AND PROCEDURES
The schedule below is a representation of procedures that will be accomplished at each study stage.

CONFIDENTIALITY
All information you provide is considered confidential; all identifiable information collected during this study will be kept
confidential and will not be shared with anyone outside the study unless required by law. You will not be named in any reports,
publications, or presentations that may come from this study. Data collected during this study will be stored on an encrypted,
password-protected, locked external drive in a secure and confidential location for 7 years, as per Western’s data retention policy.
Once the data retention period is over, the data will be analysed by the student investigator for significance and will be stored on
a password-protected, encrypted Personal Vault via OneDrive. Access to this data will be restricted to the principal investigator
and student investigator. Western University Health Sciences Research Ethics Board may require access to the study records to
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monitor the conduct of the research. The type of personal information that will be collected is age, gender, and ethnicity. Contact
information of the participants will also be collected for this study. A description of this study will be available by contacting the
student investigator at bsalmani@uwo.ca. You can contact the student investigator via email, at any time, regarding any questions
and/or concerns related to this study.
VOLUNTARY PARTICIPATION
Participation in this study is voluntary. If you wish, you may decline to answer any questions or participate in any component of
the study without effect on academic standing. Further, without effect on academic standing, you may also decide to withdraw
from this study at any time. If you do wish to no longer be included in the study or you are removed as a participant and wish to
withdraw your past questionaries from the study, you should tell the Principal Investigator, Dr. Harry Prapavessis, who will
ensure no future data will be collected, the data related to your participation in the study will be removed, and you will no longer
receive questionnaires from the study staff. You as a participant may be taken off the study if you are unable to tolerate the study
intervention, if you are unable to complete all required study procedures, or if the research ethics board withdraws permission for
this study to continue. If this happens, it may mean that you would not receive the study intervention for the full period described
in this consent form. If you are removed from this study, the study staff will discuss the reasons with you.
It is important to recognize that email is not secure. Email data can be stolen as it travels over the network and could be stored on
mail servers, internet mail relays, as well as end devices. If, at any point, you feel unsafe or choose to no longer communicate on
this platform, please email the student investigator and they will withdraw you from further study procedures and protocols. You
will receive a copy of this letter of information and signed Informed Consent.
PUBLICATION OF RESULTS
Results of this study may be published in professional journals and presented at conferences. Feedback about this study will be
available approximately 6 months after the completion of the study. If you wish to receive the results of the study, please provide
either your email or mailing address: ___________________________________________
CONTACT INFORMATION
If you have any questions about your rights as a research participant or the conduct of this study, you may contact The Office of
Human Research Ethics (519) 661-3036, 1-844-720-9816, email: ethics@uwo.ca. The REB is a group of people who oversee the
ethical conduct of research studies. The HSREB is not part of the study team. Everything that you discuss will be kept
confidential. Thank you for your assistance in this project. Please keep a copy of this form for your records.

CONSENT FORM
Study Title: Information Interventions to Reduce Vaping in a Student Population
This study has been explained to me and any questions I had have been answered.
I know that I may leave the study at any time. I agree to take part in this study.
_________________________

_______________

______________________

Print Name of Participant

Signature

Date (DD-MM-YYYY)

_________________________

_______________

______________________

Signature

Date (DD-MM-YYYY)

Name of Person Obtaining Consent
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Exclusion from Study Explanation

Exclusion from Study Explanation
Study Title: Information Interventions to Reduce Vaping in a Student Population
Principal Investigator:
Dr. Harry Prapavessis, PhD
Department of Kinesiology
Western University
hprapave@uwo.ca

Student-Investigator:
Babac Salmani, MA
Department of Kinesiology
Western University
bsalmani@uwo.ca

Date: [Insert Date]
Dear Student:
Hello, my name is Babac Salmani and I am the Student Investigator (SI) in the 6-week study on
vaping behaviour among students at Western University. As part of the research investigation,
participants are responsible for completing 12 self-report questionnaires on three separate timepoints within the 6-week study period. Although 7 additional days are provided to participants to
submit their questionnaires from the day they are received, because you have failed to
successfully submit your questionnaires on-time, you have been removed from the study. Since
all submitted questionnaire responses are anonymous, we are unable to recover any past data,
however your data will continue to remain unidentified.
Participation is voluntary and there are no consequences for choosing not to participate or
withdrawing from the study. Confidentiality of all participants will be maintained. The data will
be kept secure and password protected.
Any additional questions regarding the project can be directed to me, Babac Salmani at
bsalmani@uwo.ca.
Respectfully,
Babac Salmani
Student Investigator
Western University
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Follow-up Email for Missed Questionnaire

Follow-up Email for Missed Questionnaire
Study Title: Information Interventions to Reduce Vaping in a Student Population
Principal Investigator:
Dr. Harry Prapavessis, PhD
Department of Kinesiology
Western University
hprapave@uwo.ca

Student-Investigator:
Babac Salmani, MA
Department of Kinesiology
Western University
bsalmani@uwo.ca

Date: [Insert Date]
Dear Student:
Hello, my name is Babac Salmani and I am the Student Investigator (SI) in the 6-week study on
vaping behaviour among university students in Canada. As part of the research investigation,
participants are responsible for completing 12 self-report questionnaires on four separate timepoints within the 6-week study period.
I am emailing to remind you to complete a questionnaire that has not been successfully
submitted on https:/www.surveymonkey.com. 7 additional days are provided to participants to
submit their questionnaires from the day they are sent out; in order to remain as a participant in
the study, these questionnaires must be complete and submitted within the next 3 days or you
may be withdrawn from the study. Please take a moment and complete the questionnaires linked
below:
[Insert links to qualtrics.com questionnaire(s)]
We are excited to gather your feedback to help expand the understanding around vaping
behaviour.
Participation is voluntary and there are no consequences for choosing not to participate or
withdrawing from the study. Confidentiality of all participants will be maintained. The data will
be kept secure and password protected.
Any additional questions regarding the project can be directed to the SI, Babac Salmani at
bsalmani@uwo.ca.
Respectfully,
Babac Salmani
Student Investigator
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Follow-up Email for LOI/Consent

Follow-up Email for LOI/Consent
Study Title: Information Interventions to Reduce Vaping in a Student Population
Principal Investigator:
Dr. Harry Prapavessis, PhD
Department of Kinesiology
Western University
hprapave@uwo.ca

Student-Investigator:
Babac Salmani, MA
Department of Kinesiology
Western University
bsalmani@uwo.ca

Date: [Insert Date]
Dear Student:
Hello, my name is Babac Salmani and I am the Student Investigator (SI) in the 6-week study on
vaping behaviour among university students in Canada.
As a valued participant in our study, we are excited to gather your feedback to help expand the
understanding around vaping behaviour. As the popularity of vaping products in Canada
continue to rise, the purpose of this study is focused on finding out what effects an individual’s
behaviour-intention and action-behaviour and how we can potentially reduce and manage the
uptake of vaping behaviour in Canadian students. As you have shown some interest in
involvement, please take a few minutes and review the Letter of Information/Consent attached to
this email and submit a signed copy to the SI email shown here: bsalmani@uwo.ca.
7 additional days are provided to participants to review and submit their acknowledgment of the
study considerations and interventions from the day they are sent out; in order to become a
participant, the Letter of Information/Consent form must be complete and submitted within this
time. This is a follow-up email; failure to submit a signed copy to the SI within 4 days from this
email being sent, will result in the termination of your potential participation.
Participation is voluntary and there are no consequences for choosing not to participate or
withdrawing from the study. Confidentiality of all participants will be maintained. The data will
be kept secure and password protected.
Any additional questions regarding the project can be directed to me, Babac Salmani at
bsalmani@uwo.ca.
Respectfully,
Babac Salmani
Student Investigator
Western University
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Day 1 (Baseline) Email

Study Title: Information Interventions to Reduce Vaping in a Student Population
Principal Investigator:
Dr. Harry Prapavessis, PhD
Department of Kinesiology
Western University
hprapave@uwo.ca

Student-Investigator:
Babac Salmani, MA
Department of Kinesiology
Western University
bsalmani@uwo.ca

Date: [Insert Date]
Dear Student:
Hello, this is Babac Salmani, the Student Investigator (SI) in the 6-week study on vaping
behaviour among students at Western University. This form is being sent to you because you
have reached the Day 1 (Baseline) of the study protocol. As part of the research investigation,
participants are responsible for completing 12 self-report questionnaires on three separate timepoints within the 6-week study period.
As a valued participant in our study, we are excited to gather your feedback to help expand the
understanding around vaping behaviour. Can you take a few minutes and complete the selfreport questionnaires? I have included the links below:
[Insert links to qualtrics.com questionnaire(s)]
7 additional days are provided to participants to submit their questionnaires from the day they are
sent out; in order to remain as a participant in the study, these questionnaires must be complete
and submitted within this time.
Participation is voluntary and there are no consequences for choosing not to participate or
withdrawing from the study. Confidentiality of all participants will be maintained. The data will
be kept secure and password protected.
Any additional questions regarding the project can be directed to me, Babac Salmani at
bsalmani@uwo.ca.
Respectfully,
Babac Salmani
Student Investigator
Western University
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Day 7 (T1) Email

Study Title: Information Interventions to Reduce Vaping in a Student Population
Principal Investigator:
Dr. Harry Prapavessis, PhD
Department of Kinesiology
Western University
hprapave@uwo.ca

Student-Investigator:
Babac Salmani, MA
Department of Kinesiology
Western University
bsalmani@uwo.ca

Date: [Insert Date]
Dear Student:
Hello, this is Babac Salmani, the Student Investigator (SI) in the 6-week study on vaping
behaviour among students at Western University. This form is being sent to you because you
have reached the Day 7 (T1) of the study protocol. As part of the research investigation,
participants are responsible for completing 12 self-report questionnaires on four separate timepoints within the 6-week study period.
As a valued participant in our study, we are excited to gather your feedback to help expand the
understanding around vaping behaviour. Can you take a few minutes and complete the selfreport questionnaires? I have included the links below:
[Insert links to qualtrics.com questionnaire(s)]
7 additional days are provided to participants to submit their questionnaires from the day they are
sent out; in order to remain as a participant in the study, these questionnaires must be complete
and submitted within this time.
Participation is voluntary and there are no consequences for choosing not to participate or
withdrawing from the study. Confidentiality of all participants will be maintained. The data will
be kept secure and password protected.
Any additional questions regarding the project can be directed to me, Babac Salmani at
bsalmani@uwo.ca.
Respectfully,
Babac Salmani
Student Investigator
Western University
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Day 30 (T2) Email

Study Title: Information Interventions to Reduce Vaping in a Student Population
Principal Investigator:
Dr. Harry Prapavessis, PhD
Department of Kinesiology
Western University
hprapave@uwo.ca

Student-Investigator:
Babac Salmani, MA
Department of Kinesiology
Western University
bsalmani@uwo.ca

Date: [Insert Date]
Dear Student:
Hello, this is Babac Salmani, the Student Investigator (SI) in the 6-week study on vaping
behaviour among students at Western University. This form is being sent to you because you
have reached the Day 30 (T2) of the study protocol. As part of the research investigation,
participants are responsible for completing 12 self-report questionnaires on three separate timepoints within the 6-week study period.
As a valued participant in our study, we are excited to gather your feedback to help expand the
understanding around vaping behaviour. Can you take a few minutes and complete the selfreport questionnaires? I have included the links below:
[Insert links to qualtrics.com questionnaire(s)]
7 additional days are provided to participants to submit their questionnaires from the day they are
sent out; in order to remain as a participant in the study, these questionnaires must be complete
and submitted within this time.
Participation is voluntary and there are no consequences for choosing not to participate or
withdrawing from the study. Confidentiality of all participants will be maintained. The data will
be kept secure and password protected.
Any additional questions regarding the project can be directed to me, Babac Salmani at
bsalmani@uwo.ca.
Respectfully,
Babac Salmani
Student Investigator
Western University
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Day 45 (T3) Email

Study Title: Information Interventions to Reduce Vaping in a Student Population
Principal Investigator:
Dr. Harry Prapavessis, PhD
Department of Kinesiology
Western University
hprapave@uwo.ca

Student-Investigator:
Babac Salmani, MA
Department of Kinesiology
Western University
bsalmani@uwo.ca

Date: [Insert Date]
Dear Student:
Hello, this is Babac Salmani, the Student Investigator (SI) in the 6-week study on vaping
behaviour among students at Western University. This form is being sent to you because you
have reached the Day 45 (T3) of the study protocol. As part of the research investigation,
participants are responsible for completing 12 self-report questionnaires on three separate timepoints within the 6-week study period.
As a valued participant in our study, we are excited to gather your feedback to help expand the
understanding around vaping behaviour. Can you take a few minutes and complete the selfreport questionnaires? I have included the links below:
[Insert links to qualtrics.com questionnaire(s)]
7 additional days are provided to participants to submit their questionnaires from the day they are
sent out; in order to remain as a participant in the study, these questionnaires must be complete
and submitted within this time.
Participation is voluntary and there are no consequences for choosing not to participate or
withdrawing from the study. Confidentiality of all participants will be maintained. The data will
be kept secure and password protected.
Any additional questions regarding the project can be directed to me, Babac Salmani at
bsalmani@uwo.ca.
Respectfully,
Babac Salmani
Student Investigator
Western University
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Demographics Questionnaire
Please answer the following questions to the best of your ability and as truthfully as
possible.
1. What is your age?
 : ____________
2. What year are you in?
 1st Year
 3rd Year
 2nd Year
 4th Year

 Other

3. What is your gender?
 Male
 Other
 Female
 Prefer not to say
5. What is your ethnicity:
 Caucasian
 African/African American
 Hispanic/Hispanic American

 Asian/Asian American
 Aboriginal Peoples of Canada
 Other

6. What is your approximate household income?
 Under $25,000
 $60,000-$100,000
 $25,000-$60,000
 $100,000-$150,000

 Prefer not to answer

7. What is your current employment status while in school?
 Employed Full-Time (>40 hrs/wk)
 Employed Part-Time (<40 hrs/wk)
 Unemployed
 Self-Employed
8. Which Canadian university are you currently enrolled under?
 : ____________
9. What is your study number?
 : ____________
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Youth Vaping Questionnaire (YVQ-A)
1. How old were you when you first tried vaping?
 10 or younger
 10-15
 16-18
 19 or older
2. Do your parents or another family member regularly vape at home?
 Yes
 No
3. How many of your four closest friends vape?
 None
 One
 Two
 Three
 All Four
4. If one of your friends were to offer you a vape, would you smoke it?
 Definitely yes
 Definitely not
 Probably yes
 Probably not
5. During the past 30 days, how many times did you vape?
0
 1-5
 5-15
 16-29
 More than 30
6. During the past 30 days, how did you get your own vaping pods?
 I did not buy or vape
 I bought them myself
 I had someone else buy them for me  I borrowed them
 I got them some other way
7. Have you ever used chewing tobacco, cigarettes, cigars, cigarillos, or little cigars?
 Yes
 No
 Prefer not to say
8. What is your study number?
 : ____________
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PMT Questionnaire I
Instructions
The following questions ask you about your perceptions of vaping-related health risks,
the severity of those risks, and the potential link between the two. There are no right or
wrong answers. All we ask is that you provide honest responses. All responses are
completely confidential and will never be used in any way that could link them to you. It
is important to complete all questions so that we can include your responses in our
analyses. If you have any questions about completing the questionnaire, please email
the research assistant.
Please complete each question using the scales that are provided. Circle the number that
best represents your choice.
1. Personally, I feel vulnerable to developing health problems at some point because
of vaping.
1
Strongly
Disagree

2

3

4

5

6

7

8

9

10
Strongly
Agree

2. I feel that my chance of developing health problems at some point because of
vaping is:
1
Extremely
Low

2

3

4

5

6

7

8

9

10
Extremely
High

3. I think it is likely that I will develop health problems at some point because of
vaping.
1
Strongly
Disagree

2

3

4

5

6

7

8

9

10
Strongly
Agree

4. Compared to the average person, I feel that my chance of developing health
problems is:
1
Much
Lower

2

3

4

5

6

7

8

9

10
Much
Higher

5. I feel that it would be very serious for me to develop health problems if I continue
to vape.
1
Strongly
Disagree

2

3

4

5

6

7

8

9

10
Strongly
Agree
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6. If you developed health problems as a result of vaping, how much would it
interfere with you leading a normal life?
1
Not At All

2

3

4

5

6

7

8

9

10
Very Much

7. I feel that if I were to develop health problems, it would seriously affect me for the
rest of my life.
1
Strongly
Disagree

2

3

4

5

6

7

8

9

10
Strongly
Agree

8. The thought of developing health problems as a result of vaping scares me.
1
Strongly
Disagree

2

3

4

9. What is your study number?

5

6

7

8

9

10
Strongly
Agree
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PMT Questionnaire II
Instructions
The following questions ask you about your perceptions of vaping-related health risks,
the severity of those risks, and the potential link between the two. There are no right or
wrong answers. All we ask is that you provide honest responses. All responses are
completely confidential and will never be used in any way that could link them to you. It
is important to complete all questions so that we can include your responses in our
analyses. If you have any questions about completing the questionnaire, please email
the research assistant.
Please complete each question using the scales that are provided. Circle the number
that best represents your choice.
1. How effective do you feel reducing the amount you vape would be for lowering
your risk of health problems?
1
Not At All

2

3

4

5

6

7

8

9

10
Very

2. I feel that the evidence linking vaping abstinence to health problem reduction is
very strong.
1
Strongly
Disagree

2

3

4

5

6

7

8

9

10
Strongly
Agree

3. For me, reducing the amount I vape or remaining abstinent from vaping to
decrease my risk of developing health problems would be:
1
Extremely
Difficult

2

3

4

5

6

7

8

9

10
Extremely
Easy

4. If I wanted to, I could easily reduce the amount I vape or remain abstinent from
vaping to reduce my risk of developing health problems.
1
Strongly
Disagree

2

3

4

5

6

7

8

9

10
Strongly
Agree

5. How much control do you have over reducing the amount you vape and your
ability to remain abstinent from vaping to reduce your risk of developing health
problems?
1
Very Little
Control

2

3

4

5

6

7

8

9

10
Complete
Control
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6. How confident are you that you are capable of reducing the amount you vape and
your ability to remain abstinent from vaping to reduce your risk of developing health
problems?
1
Not At All
Confident

2

3

4

5

6

7

8

9

10
Completely
Confident

7. How likely is it that preventing health problems would motivate you to reduce
vaping?
1
Extremely
Unlikely

2

3

4

5

6

7

8

9

10
Extremely
Likely

8. Would you seriously consider starting a structured program designed to help you
reduce or quit vaping to decrease your risk of developing health problems?
1
Not At All

2

3

4

5

6

7

8

9

10
Very
Seriously

9. Do you plan to start a structured program designed to help you quit vaping and
reduce your risk of health problems in the near future?
1
Definitely
Not

2

3

4

10. What is your study number?

5

6

7

8

9

10
Definitely
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Debriefing Letter

The Effectiveness of the Protection Motivation Theory in Reducing
Vaping Behaviour in a Student Population
Thank you for your participation!
Thank you for taking the time to participate in our study on using information interventions to reduce
vaping in a Canadian student population! You were randomly assigned to one of two groups: the first
received an educational video about the perceived vulnerability and severity of vaping behaviour and its
role on overall health; the second group received the same video format but focused on features of
nutrition and lifestyle information and they’re subsequent health impact. The study aimed to examine
whether information about specific vaping-related health problems can serve as an effective strategy to
reduce and potentially quit the habit, and whether providing educational outlets focused on perceived
vulnerability or severity would contain a difference in benefits between the two threat narratives.
Quitting any negative-health habit is not without its challenges and finding the time, motivation, and
adherence to remain abstinent from the behaviour can be particularly difficult during this period of life –
especially if you have negative influences around you! Trying to overcome the barriers associated with
stress and anxiety can lead to worse habitual behaviours.
For this reason, you are invited to look into the resources at Health Canada at
https://www.canada.ca/en/health-canada/services/smoking-tobacco/vaping/smokers.html or by contacting
their support and advice line at 1(866)-366-3667. If you notice a significantly greater sense of mental
distress or anxiety as a result of participation in the study procedures, please contact Dr. Lisa Lee, a
clinical psychologist as part of the study team, by email at info@drlisalee.com, or by phone at (519) 8784912. In addition, the Counselling Services of London, specialized in anxiety therapy and self-esteem
counselling, have offered their services as part of our study team at counselling@natashaminor.com or by
phone at (226) 270-1242, to any participants who feel distress. Both study team resources offer online
services for study participants. Lastly, please consider contacting the Centre for Addiction and Mental
Health in Canada, at (519) 858-5144 if you feel the need for additional aid. These resources may provide
suggestions to help answer questions about vaping and eliminate some of the stress associated with trying
to quit a negative habit.
In addition, please keep the Letter of Information/Consent in the case that you wish to contact the
researchers or request a copy of the results.
Once again, thank you very much for you time.
Sincerely,
Principal Investigator:
Dr. Harry Prapavessis, PhD
Department of Kinesiology
Western University
Hprapave@uwo.ca

Co-Investigator:
Babac Salmani, MA
Department of Kinesiology
Western University
Bsalmani@uwo.ca
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